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FSP Section 21,000
CHECKLISTS AND ILLUSTRATIVE 
FINANCIAL STATEMENTS FOR HEALTH 
CARE PROVIDERS
.01 The checklists and illustrative financial statements included in this section have been developed by the 
staff of the Technical Information Division of the AICPA as nonauthoritative technical practice aids. Readers 
should be aware of the following:
• The checklists and illustrative financial statements do not include all disclosures and presentation items 
promulgated. Pronouncements deemed remote for audits of health care providers are not included in this 
document.
• The checklists and illustrative financial statements are "tools" and in no way represent official positions 
or pronouncements of the AICPA.
• The checklists and illustrative financial statements have been updated through FASB Statement No. 120, 
FASB Interpretation No. 41, FASB Technical Bulletin No. 94-1, AICPA Statement of Position No. 95-1, 
AICPA Statement on Auditing Standards No. 74, AICPA Statement on Standards for Accounting and 
Review Services No. 7, EITF Consensuses adopted up to and including the January 19, 1995 Emerging 
Issues Task Force meeting, and AICPA Audit and Accounting Guide, Audits of Providers of Health Care 
Services (with conforming changes as of May 1, 1994). The checklists and illustrative financial state­
ments should be modified, as appropriate, for subsequent pronouncements. In determining the applica­
bility of a pronouncement, its effective date should also be considered.
• In June 1993, the FASB issued Statements of Financial Accounting Standards (SFAS) No. 116, Account­
ing for Contributions Received and Contributions Made, and No. 117, Financial Statements of Not-for- 
Profit Organizations. SFAS No. 116 changes the accounting for contributions as presently set forth in 
SOP 78-10 and in the Audits of Providers of Health Care Services Guide. SFAS No. 117 establishes 
standards for not-for-profit organizations general purpose external financial statements. SFAS Nos. 116 
and 117 are effective for financial statements issued for fiscal years beginning after December 15, 1994, 
except for organizations with less than $5 million in total assets and less than $1 million in annual 
expenses. For those organizations, the Statements are effective for fiscal years beginning after December 
15, 1995. Earlier application is encouraged. Disclosures relating to those Statements are presented in 
Exhibit B.
• The checklists and illustrative financial statements should be used by, or under the supervision of, 
persons having adequate technical training and proficiency in the application of generally accepted 
accounting principles, generally accepted auditing standards, and statements on standards for accounting 
and review services.
.02 Users of the checklists and illustrative financial statements are urged to refer directly to applicable 
authoritative pronouncements when appropriate. If you have further questions, call the AICPA Technical Hotline.
Note: This publication was extracted from sections 21,000 through 21,500 of the AICPA Financial Statement Preparation Manual (FSP).
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Introduction
.01 Health care costs, as well as the number of people requiring health care services, have consistently risen. 
As a result, many health care providers are relying more heavily on debt financing to meet capital needs creating a 
greater need for accountability to creditors and investors.
.02 Health care entities may be classified by sponsorship or legal structure within three broad categories: 
voluntary (not-for-profit), governmental, and investor- (or operator-) owned.
Voluntary (not-for-profit): an entity that operates under the direction of governing boards. Usually 
exempt from federal and state income taxes if operated exclusively for religious, charitable, scientific or 
educational purposes, the entity may be further classified as community-based, religious affiliated or 
university-sponsored.
Governmental: often called public health care entities, the entity is owned and operated by federal, state, 
city or county governments or other political subdivisions.
Investor- (or Operator-) Owned: a health care entity that operates as a stock corporation, partnership or 
sole proprietorship.
.03 Health care entities include, but are not limited to, the following:
• Clinics, medical group practices, individual practitioners and practice associations, and other ambulatory 
care organizations.
• Continuing care retirement communities (CCRCs).
• Health maintenance organizations and similar prepaid health care plans.
• Home health agencies.
• Hospitals.
• Nursing homes that provide skilled, intermediate, and less intensive levels of health care.
• Parent, holding and other organizations that primarily plan, organize and oversee health care services.
Legislation and Regulation
.04 Significant aspects of health care entity operations are affected by government legislation and regulation 
with many states adopting laws governing the granting of licenses, as well as scope of services to be rendered. In 
addition, many independent organizations and governmental agencies, including Medicare and Medicaid, evalu­
ate programs and services of health care entities to determine compliance with set standards.
Basic Financial Statements
.05 The basic financial statements of not-for-profit and governmental health care entities generally consist of a 
balance sheet, statement of revenues and expenses of general funds, statement of changes in fund balances, and a 
statement of cash flows of general funds (and restricted funds of governmental entities). The basic financial 
statements of investor-owned health care entities are similar to those of other investor-owned entities. Aggregated 
(combined fund) and disaggregated (layered fund) balance sheets are acceptable alternatives to reporting financial 
position of not-for-profit health care entities and governmental hospitals.
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Applicability of the Checklist
06. This checklist, and the illustrative financial statements included herein, follow the guidance contained in 
the May, 1994 edition of the AICPA Audit and Accounting Guide, Audits of Providers of Health Care Services. 
Although the Guide applies also to state and local government-owned health care providers, this checklist does 
not include disclosures or sample financial statements of government-owned providers. Governmental health care 
providers should follow the interim guidance in.the Governmental Accounting Standards Board (GASB) State­
ment No. 20, Accounting and Financial Reporting for Proprietary Funds and Other Governmental Entities That 
Use Proprietary Fund Accounting, until the GASB completes its project on business-type activities. Governmental 
proprietary activities should apply all applicable GASB pronouncements as well as any Financial Accounting 
Standards Board (FASB) Statements and Interpretations, Accounting Principle Board (APB) Opinions, and Ac­
counting Research Bulletins (ARBs) issued on or before November 30, 1989, that do not conflict with or contradict 
GASB pronouncements. Furthermore, paragraph 7 of GASB Statement No. 20 provides that governmental 
proprietary activities may apply all FASB Statements and Interpretations issued after November 30, 1989, that do 
not conflict with or contradict GASB pronouncements. Entities that choose to apply these "new" FASB pro­
nouncements must apply them on an "all or none" basis (that is, they may not select which pronouncements to 
apply).
07. On April 14, 1995, the AICPA issued an exposure draft on a new Audit and Accounting Guide, Health 
Care Organizations (the proposed Guide), that would supersede the existing Guide and also Statements of 
Position (SOPs), 89-5, Financial Accounting and Reporting by Providers of Prepaid Health Care Services, and 
90-8, Financial Accounting and Reporting by Continuing Care Retirement Communities. The requirements in the 
proposed Guide, inasmuch as they pertain to governmental health care providers, generally apply to providers 
who apply paragraph 7 of GASB Statement No. 20 (see previous paragraph). The deadline for comments on the 
proposed Guide is August 14, 1995.
08. Health care providers who choose to early adopt the provisions of FASB Statements No. 116, Accounting 
for Contributions Received and Contributions Made, and No. 117, Financial Statements of Not-for-Profit Organi­
zations, should consider the items in Exhibit B of this Checklist in addition to the other appropriate disclosures 
contained in the Checklist.
09. The GASB has issued an exposure draft of a proposed Statement, The Use of Not-for-Profit Accounting 
and Financial Reporting Principles by Governmental Entities. The proposed Statement would provide that 
proprietary activities that apply the provisions of paragraph 7 of GASB Statement No. 20 should apply only those 
"new" FASB Statements and Interpretations that are developed for business enterprises, rather than those whose 
provisions are limited to not-for-profit organizations or address issues primarily concerning such organizations 
(such as FASB Statements No. 116 and 117).
.10 Not-for-profit health care providers that receive federal financial assistance may be required to have an 
audit conducted in accordance with Office of Management and Budget (OMB) Circular A-133, Audits of 
Organizations of Higher Education and Other Nonprofit Organizations. Section 21,500 includes a checklist for 
auditor's reports for audits performed under OMB Circular A-133.
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Checklists—General
.01 Many auditors and accountants find it helpful to use checklists as practice aids in the preparation of 
financial statements and reports. Some firms have developed their own checklists for internal use and may also 
have specialized checklists to meet the needs of their practices, such as checklists for clients in particular industries 
or clients that report to the SEC. Some state CPA societies have developed checklists as practice aids that may be 
available to other practitioners, as well as to their own members. Some commercial publishers also include 
checklists in certain of their publications. However, authoritative literature does not require the use of such 
checklists, nor does it prescribe their format or content, which may vary.
.02 Checklists typically consist of a number of brief questions or statements that are accompanied by 
references to Statements on Auditing Standards, Statements on Standards for Accounting and Review Services, 
Statements of Financial Accounting Standards, Accounting Principles Board Opinions, and Accounting Research 
Bulletins. Some checklists also include references to FASB Interpretations, Statements of Position, and the AICPA 
Audit and Accounting Guides. The extent of detail included in checklists varies with the judgment of the preparers 
on how extensively to refer to and highlight authoritative literature without developing a checklist that is too long 
and unwieldy. Accordingly, checklists may serve as convenient memory aids but cannot be used as a substitute for 
direct reference to the authoritative literature.
.03 Checklists usually provide for checking off or initialling each question or point to show that it has been 
considered. The format used herein is a typical one; it provides for "yes," "no," and "not applicable" answers and 
presumes that remarks would be prepared on separate cross-referenced memorandums. Some preparers, however, 
prefer to include space for remarks in the body of the checklist, while others prefer alternative checklist formats. 
For example, a checklist format may provide for the following set of answers: "not applicable," "not material," "in 
statements," and "in notes" (with provisions for indicating a cross-reference to the specific statement caption or 
note). Another format may provide for only two answers, "disclosed" and "not applicable." Firms and practition­
ers who develop their own checklists should adopt formats that suit their needs and preferences.
.04 Checklists are generally accompanied by caveats that include all of the following points:
• Use of the checklists requires the exercise of individual professional judgment and may likely require 
some modification based on the circumstances of individual engagements.
• The checklists are not all-inclusive and are not intended to present minimum requirements.
• Users need to modify the checklists for any pronouncements issued subsequent to those mentioned in 
the checklist.
.05 If widespread circulation is expected, the preparers also generally stress the nonauthoritative or unofficial 
status of the checklists and disclaim responsibility for the way they may be used.
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Financial Statements and Notes Checklist
.01 This checklist has been developed by the staff of the Technical Information Division of the AICPA as a 
nonauthoritative practice aid.
.02 Explanation of References:
AAG = AICPA Audit and Accounting Guide, Audits of Providers of Health Care Services (with
conforming changes as of May 1, 1994)
AC = Reference to section number in FASB Accounting Standards—Current Text
APB = AICPA Accounting Principles Board Opinion
ARB = AICPA Accounting Research Bulletin
AU = Reference to section number in AICPA Professional Standards (vol. 1)
FASBI = FASB Interpretation
FASCON = FASB Statement of Financial Accounting Concepts 
SAS = AICPA Statement on Auditing Standards
SFAS = FASB Statement of Financial Accounting Standards
SOP = AICPA Statement of Position
TB = FASB Technical Bulletin
.03 Checklist Questionnaire
Yes No N/A
I. Accounting Principles of Display and Disclosure
A. Fund Accounting
1. General funds
a. For classified balance sheets, are assets and liabilities classified as current and
noncurrent, with totals presented for current assets and current liabilities? _____
[AAG, par. 3.04; ARB 43, Ch. 3A (AC B05.103—.109); SFAS 6, par. 15 (AC 
B05.118); TB 79-3 (AC B05.501—.503)]
b. Are agency funds (assets owned by others under agency relationships (such
as patients or physicians) and their related liabilities) reported in the general 
funds? --------
c. Are transactions involving receipt and disbursement of agency funds
excluded from the results of operations? --------
[AAG, par. 3.06]
d. Is property and equipment used for general operations (and related liabilities)
reported in the general funds? --------
e. Is property and equipment not used for general operations (such as property 
acquired for future expansion or investment purposes) presented as a separate
item in the general funds? --------
[AAG, pars. 3.07 and 8.06]
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Yes No N/A
2. Donor-restricted funds
a. Is donor-restricted property and equipment (such as real estate investments of 
endowment funds) reported in the appropriate donor-restricted fund?
[AAG, pars. 3.07 and 8.07]
b. Are resources restricted by donors for additions to property and equipment 
reported in restricted plant replacement and expansion funds?
c. Are plant replacement and expansion funds reported in the statement of 
changes in fund balances when expenditures are incurred for the purpose 
intended by the donor?
[AAG, par. 3.10]
d. Do "term endowment funds" include resources whose principal may be 
expended after the donor-imposed time or after other restrictions are 
satisfied?
e. Is all pertinent information about term endowment funds (such as term and 
purposes) disclosed in the notes?
f. Are term endowment funds available for unrestricted purposes reported in 
the statement of revenues and expenses?
g. Are term endowment funds that became available, but are further restricted 
under the term endowment provisions, shown as a reclassification to the 
appropriate donor-restricted fund in the statement of changes in fund 
balances?
[AAG, par. 3.11]
h. Do endowment funds include resources whose principal may not be 
expended?
[AAG, par. 3.13]
6. Donated Funds Held in Trust
1. If donated resources are held in a trust (by an independent trustee), of which the 
provider is not the remainderman:
a. Are they excluded from the balance sheet?
b. Is their existence disclosed?
[AAG, par. 3.14]
2. Is disclosure considered of the right to future income and the principal held in 
trust?
[AAG, par. 3.15]
3. If the provider received a distribution, is it reported in accordance with the terms 
of the trust or agreement with the trustee?
[AAG, par. 3.15]
4. If the provider is the remainderman, are the donated funds reported as assets
(depending on the terms of the trust document)?
[AAG, par. 3.16]
C. Financial Statements
1. For not-for-profit and governmental providers, do the basic financial statements 
include:
a. A balance sheet?
b. A statement of revenues and expenses of general funds?
c. A statement of changes in fund balances?
d. A statement of cash flows of general funds (and restricted funds of 
governmental entities)?
[AAG, par. 3.24]
2. For investor-owned providers, are the basic financial statements similar to those 
of other investor-owned providers?
[AAG, par. 3.24]
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Yes No N/A
II. Cash and Cash Equivalents
A. General
1. Is restricted cash appropriately segregated from cash available for current
operations? _____ _____ _____
[ARB 43, Ch. 3A, par. 6 (AC B05.107)]
2. Are restrictions on cash (such as for plant acquisition, debt reduction or working
capital maintenance) appropriately disclosed? _____ _____ _____
[SFAS 5, pars. 18—19 (AC C59.120)]
B. Personal Fund Accounts
1. Are personal funds of patients, residents and others under an agency
arrangement reported as assets and corresponding liabilities in the balance sheet? _____ _____ _____
[AAG, par. 5.06]
2. Is the amount of personal funds reported as assets disclosed parenthetically on
the balance sheet or in the notes? _____ _____ _____
[AAG, par. 5.06]
C. Cash Equivalents
1. Is the policy for determining cash equivalents disclosed? _____ _____ _____
[SFAS 95, par. 10 (AC C25.108)]
III. Investments1 (Not-for-Profit Entities see Exhibit A)
1 SFAS 115 is not applicable to not-for-profit health care providers. Not-for-profit health care providers should continue to follow the 
guidance in section 6.02 of the AICPA Audit and Accounting Guide, Audits of Providers of Health Care Services. See also Exhibit A to this 
checklist.
A. General
1. Are investments of general funds reported as current or noncurrent assets in
conformity with GAAP? _____ _____ _____
[AAG, par. 6.01]
2. Are the appropriate disclosures made for investments in common stock
accounted for by the equity method? -------- -------- -------
[APB 18, par. 20 (AC I82.110)]
3. Are other securities (such as real estate) reported at amortized cost, or at lower of
cost or market if an impairment in value is deemed to be other than temporary? -------- -------- -------
[AAG, par. 6.02c]
B. Debt and Equity Securities1 (Not-for-Profit Entities see Exhibit A)
1. For debt and marketable equity securities classified as available-for-sale or held- 
to-maturity, are the following disclosures made, by major-security type, for each 
balance sheet presented:
a. Aggregate fair value? -------- -------- -------
b. Gross unrealized holding gains or losses? -------- -------- -------
c. Amortized cost basis? -------- -------- -------
d. Disclosure of major-security types, including:
(1) Equity securities? -------- -------- -------
(2) Debt securities issued by the U.S. Treasury and other U.S. government
corporations and agencies? --------- --------- --------
(3) Debt securities issued by states of the U.S. and political subdivisions of
the states? -------- -------- -------
(4) Debt securities issued by foreign governments? -------- -------- -------
(5) Corporate-backed securities? -------- -------- -------
(6) Mortgage-backed securities? --------- --------- --------
(7) Other debt securities? -------- -------- -------
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Yes No N/A
(8) Other security types, as deemed appropriate? _____
[SFAS 115, par. 19 (AC I80.118)]
2. For investments in debt securities classified as available-for-sale or held-to- 
maturity is:
a. Disclosure made about their contractual maturities, as of the date of the latest
balance-sheet date presented (maturity information may be combined in 
appropriate groupings)? _____
b. Disclosure made of the fair value and the amortized cost of debt securities in 
at least four maturity groupings:
(1) Within one year? _____
(2) After one year through five years? _____
(3) After five years through ten years? _____
(4) After ten years? _____
[SFAS 115, par. 20 (AC I80.119)]
3. Is consideration given to separate disclosure for securities not due at a single date
and the basis for allocation if such securities are allocated? _____
[SFAS 115, par. 20 (AC I80.119)]
4. Are realized gains or losses on the sale of investments of endowment funds
added to or deducted from the funds' principal (unless such amounts are legally 
available for other use or chargeable to other funds)? _____
[AAG, par. 6.13]
5. Are income and net realized gains or losses on investments of restricted funds 
(other than endowment funds) added to or deducted from the respective fund 
balance (unless such amounts are legally available for other use or chargeable to
other funds)? _____
a. If such amounts are legally available for unrestricted purposes, are they
reported in the statement of revenues and expenses? _____
b. Are gains or losses on investment trading between general and restricted 
funds and between various categories of restricted funds (such as between 
endowment and plant expansion funds) separately disclosed in the financial
statements? _____
[AAG, par. 6.14]
IV. Receivables
1. Are charity care revenue and receivables excluded from the financial statements? _____
[AAG, par. 7.02]
2. Are differences between the estimates originally reported and final settlements:
a. Included in the statement of revenues and expenses (statement of operations)
in the period the settlements are made? _____
b. Reported in the current period unless they meet the criteria for prior-period
adjustments? _____
[AAG, par. 7.09; SFAS 16 (AC A35)]
3. Are advances from third-party payors reported as a liability (unless the right of
setoff against a related receivable applies)? _____
[AAG, par. 7.11]
4. Are deposits received from individuals reported as a liability (to the extent that a
right of setoff does not exist)? _____
[AAG, par. 7.12]
5. Are receivables (less an allowance for uncollectibles, discounts, and contractual
adjustments) reported as current assets in the general funds? _____
a. If the terms of payment are extended beyond one year from the balance-sheet
date, is that portion classified as noncurrent? _____
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Yes No N/A
b. Is consideration given to segregating amounts due from third-party payors for
retroactive adjustments of items (such as final settlements or appeals)? _____ _____ ____
[AAG, par. 7.16]
6. If financial statements present assets and liabilities by fund groups:
a. Are interfund receivables or payables reported separately by fund? _____ _____ _____
b. In a classified balance sheet, are they reported as current or noncurrent in
general funds? _____ _____ _____
[AAG, par. 7.17]
7. If financial statements do not present assets and liabilities by fund groups, are
interfund receivables and payables eliminated? _____ _____ _____
[AAG, par. 7.17]
8. Are circumstances and terms of formal interfund borrowing agreements
disclosed? _____ _____ _____
[AAG, par. 7.17]
9. Are pledges reported in the period in which they were made? _____ _____ _____
a. Are pledges reported net of an allowance for uncollectible amounts? _____ _____ _____
b. Are unrestricted pledges reported in the statement of revenues and expenses
(statement of operation)? -------- -------- -------
c. If a portion of a pledge is to be applied during some future period, is that part 
reported in the general fund in the period in which it is received as deferred
revenue or, if restricted, as an addition to donor-restricted funds? -------- -------- -------
d. If pledges are restricted in any other way, are they reported as additions to
donor-restricted funds? -------- -------- -------
[AAG, par. 7.18]
10. Are all receivables reported net of any related allowance for uncollectible
amounts, with appropriate disclosure? -------- -------- -------
[AAG, par. 7.19; APB 12, par. 3 (AC V18.102)]
11. Are accounts and notes receivable from officers, employees, and affiliated
organizations shown separately with appropriate disclosures? -------- -------- -------
[ARB 43, Ch. 1A, par. 5 (AC R36.105)]
V. Property and Equipment, Supplies, and Other Assets
1. Is property and equipment that is donor-restricted (such as property received as a
donation to endowment funds) reported as a restricted asset? -------- -------- -------
[AAG, par. 8.07]
2. Are donor or legal restrictions on the proceeds from the disposition of property
and equipment disclosed? -------- -------- -------
[AAG, par. 8.06]
3. For depreciable assets, do the financial statements or notes disclose:
a. Depreciation expense for each period? -------- -------- -------
b. Balances of major classes of depreciable assets by nature or function? -------- -------- -------
c. Accumulated depreciation, either by major classes of assets or in total? -------- -------- -------
d. The method or methods used in computing depreciation with respect to major
classes of depreciable assets? -------- -------- -------
[APB 12, par. 5 (AC D40.105)]
4. Do disclosures include the method and period of amortization of intangible
assets? ————    
[APB 22, par. 13 (AC A10.106)]
5. In a classified balance sheet:
a. Are deferred tax assets classified as current or noncurrent based on the
classification of the related asset or liability for financial reporting? -------- -------- -------
[SFAS 109, par. 41 (AC I27.140)]
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Yes
b. Are deferred tax assets not related to an asset or liability for financial 
reporting (including those related to carryforwards) classified according to the 
expected reversal date of the temporary difference?
[SFAS 109, pars. 41 and 288p (AC I27.140)]
c. Is the valuation allowance for a particular tax jurisdiction allocated between 
current and noncurrent deferred tax assets for that tax jurisdiction on a pro
rata basis?
[SFAS 109, par. 41 (AC I27.140)]
d. Are the following items offset and presented as a single amount for a 
particular taxpaying component and within a particular taxpaying 
jurisdiction:
(1) All current deferred tax liabilities and assets?
(2) All noncurrent deferred tax liabilities and assets?
[SFAS 109, par. 42 (AC I27.141)]
6. Are the totals of (a) all deferred tax assets and (b) the related valuation allowance 
recognized in the balance sheet disclosed?
[SFAS 109, par. 43 (AC I27.142)]
7. Is an asset (prepaid pension cost) recognized if net periodic pension cost is less 
than amounts the employer has contributed to the plan?
[SFAS 87, par. 35 (P16.129)]
8. If an additional minimum pension liability is recognized, is an equal amount 
recognized as an intangible asset, provided that the asset recognized does not 
exceed the amount of unrecognized prior-service cost?
[SFAS 87, pars. 36—37 (AC P16.130—.131)]
VI. Current Liabilities, Notes Payable, and Other Debt
A. Current Liabilities
1. Do current liabilities include:
a. Obligations for items that enter the operating cycle?
b. Collections received in advance of the performance of services?
c. Debts that arise from operations directly related to the operating cycle?
d. Other liabilities whose regular and ordinary liquidation is likely to occur 
within a relatively short time period?
e. Obligations that, by their terms, are due on demand or will be due within one 
year (or operating cycle, if longer) from the balance-sheet date, even though 
liquidation may not be expected within that period?
[ARB 43, Ch. 3A, pars. 7—8 (AC B05.108—.109); SFAS 78, par. 5 (AC 
B05.109A)]
2. Do current liabilities exclude short-term obligations that the provider intends to 
refinance on a long-term basis, provided the provider has demonstrated the 
ability to consummate the long-term financing?
[SFAS 6, pars. 8—14 (AC B05.112—.116)]
B. Notes Payable and Other Debt
1. Is there adequate disclosure of interest rates, maturities, and other terms and 
conditions provided in loan agreements and bond indentures (such as assets 
pledged as collateral, and covenants to reduce debt, and maintain working 
capital)?
[FASCON 5, par. 11; SFAS 5, par. 18 (AC C59.120)]
2. Are the combined aggregate amounts of maturities and sinking fund 
requirements for all long-term borrowings disclosed for each of the five years 
following the date of the latest balance sheet presented?
[SFAS 47, par. 10b (AC C32.105b)]
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No N/A
Yes
3. If note is noninterest bearing or has an inappropriate stated interest rate:
a. Is the discount or premium presented as a deduction from or addition to the 
face amount of the note?
b. Does the disclosure include the effective interest rate and face amount of the 
note?
c. Is amortization of the discount or premium reported as interest expense?
d. Are issue costs reported in the balance sheet as deferred charges?
[APB 21, par. 16 (AC I69.109)]
4. Are debt conversion features (such as rates and pertinent dates) disclosed? 
[FASCON 5, par. 11; APB 14 (AC D10)]
5. If a short-term obligation is to be excluded from current liabilities in a classified 
balance sheet, do disclosures include:
a. General description of the financing agreement?
b. Terms of any new obligation incurred or expected to be incurred, or equity 
securities issued or expected to be issued as a result of the refinancing?
[SFAS 6, par. 15 (AC B05.118)
6. For troubled debt restructuring occurring during the current period, do 
disclosures include:
a. Description of the principal changes in terms and/or the major features of 
settlement?
b. Aggregate gain on restructuring of payables and the related income tax effect?
c. Aggregate net gain or loss on transfers of assets recognized during the period?
d. Per-share amount, if applicable, of the aggregate gain on restructuring of 
payables, net of related income tax effect?
[SFAS 15, par. 25 (AC D22.121)]
7. For periods after a troubled debt restructuring, do disclosures include:
a. Extent to which amounts contingently payable are included in the carrying 
amount of restructured payables?
b. Total amounts contingently payable, if applicable, and conditions under 
which those amounts would become payable or forgiven?
[SFAS 15, par. 26 (AC D22.122)]
8. If there is an early extinguishment of debt, is the difference between reacquisition 
price and carrying amount identified as a separate or extraordinary item?
[SFAS 4, par. 8; SFAS 64, par. 4 (AC D14.105)]
9. If debt is considered to be extinguished early, do disclosures include:
a. A general description of the transaction?
b. The amount of debt that is considered extinguished as long as the debt 
remains outstanding?
[SFAS 76, par. 6 (AC D14.108)]
10. Are long-term obligations that are or will be callable by the creditor, either 
because the debtor's violation of the debt agreement at the balance-sheet date 
makes the obligation callable, or because the violation (if not cured within a 
specified grace period) will make the obligation callable, classified as current 
unless one of the following conditions is met:
a. The creditor waives or subsequently loses the right to demand repayment for 
more than one year (or operating cycle, if longer) from the balance-sheet 
date?
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b. The obligation contains a grace period within which the debtor may cure the 
violation and it is probable that the violation will be cured within that period, 
thus preventing the violation from becoming callable?
[SFAS 78, par. 5 (AC B05.109A)]
11. Does the not-for-profit provider report tax-exempt obligations that were issued 
for its benefit as liabilities in the general funds?
[AAG, par. 9.04]
12. Is consideration given to the effects, if any, of current and prior tax examinations 
on the financial statements and disclosures related to the existence of contingent 
liabilities for unrelated business income tax, additional payroll tax liabilities, or 
penalties and interest on delinquent taxes?
[AAG, par. 9.19]
13. Is disclosure considered for any changes in the provider's activities that could 
affect its tax-exempt status?
[AAG, par. 9.20]
14. Are disclosures appropriate regarding the provider's tax-exempt status and any 
other significant tax matters?
[AAG, par. 9.21]
15. Is appropriate disclosure made if unrelated business income tax has not been 
accrued on income from:
a. Debt-financed investments that are not functionally related to the exempt 
purpose?
b. Certain related entities not engaged in an exempt activity?
c. Pharmacy operations in a medical building for the convenience of physicians' 
private patients?
d. A gift shop, cafeteria or food shop that the provider encourages the general 
public (except patients, visitors and employees) to use?
e. A parking lot available to the general public (except patients, visitors, and 
employees)?
[AAG, pars. 9.23-.32]
16. Is consideration given to disclosing the effects of the Tax Reform Act of 1986 that 
added arbitrage restrictions regarding tax-exempt bonds?
[AAG, par. 9.33]
VII. Commitments and Contingencies
A. Uninsured Medical Malpractice Claims
1. If a minimum amount of a probable loss (usually associated with litigating or 
setting malpractice claims) is accrued, is there disclosure as to a reasonable 
possibility of an additional potential loss in excess of the amount accrued?
[AAG, par. 10.04; SFAS 5 (AC C59)]
2. If a range of loss cannot be reasonably estimated, is a contingency disclosed? 
[AAG, par. 10.04; SFAS 5(AC C59)]
3. Is the program of medical malpractice coverage and basis for loss accruals 
disclosed?
[AAG, par. 10.11; SFAS 5(AC C59)]
4. If the provider discounts accrued malpractice claims, are the following disclosed:
a. The carrying amount of the claims?
b. The interest rates or other rates used to discount the claims?
[AAG, par. 10.12]
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No N/A
Yes
B. Retrospectively Rated Premiums
1. If the provider cannot estimate losses from asserted or unasserted malpractice
claims, is the existing contingency disclosed? _____
[AAG, par. 10.14; SFAS 5(AC C59)]
2. Does the provider disclose that it is insured under a retrospectively rated policy? _____
[AAG, par. 10.15]
3. Does the provider disclose that premiums are accrued based on the ultimate cost
of the experience to date of a group of entities? _____
[AAG, par. 10.15]
4. If losses cannot be estimated, is the existing contingency disclosed? _____
[AAG, par. 10.15; SFAS 5(AC C59)]
C. Medical Malpractice Claims Insured with Captive Insurance Companies 
(Controlled by a parent entity for the main purpose of providing insurance for 
the parent)
1. Does the provider disclose that it is insured under a retrospectively rated policy of
a multiprovider captive? --------
[AAG, par. 10.18]
2. Does the provider disclose that premiums are accrued based on the captive's
experience to date? --------
[AAG, par. 10.18]
3. Is the provider's ownership percentage in the captive disclosed? --------
[AAG, par. 10.19]
4. Is the method of accounting for its investment in and the operations of the
captive disclosed? --------
[AAG, par. 10.19]
5. If the provider cannot make the necessary estimates of losses from asserted or
unasserted claims, does it disclose the existing contingency? --------
[AAG, par. 10.19; SFAS 5 (AC C59)]
D. Trust Funds
1. If trust funds (revocable or irrevocable) are included in the provider's financial 
statements:
a. Is a portion of the funds (the amount of assets expected to be liquidated to 
pay malpractice claims classified as current liabilities) classified as a current
asset in a classified balance sheet? --------
[AAG, par. 10.20]
b. Is the balance of the funds, if any, classified as a noncurrent asset in a
classified balance sheet? --------
[AAG, par. 10.20]
c. Are trust fund revenue and administrative expenses included in the statement
of revenues and expenses (statement of operations)? --------
[AAG, par. 10.20]
d. Are estimated losses from asserted and unasserted claims reported? --------
[AAG, par. 10.21]
e. Is the existence of trust funds and whether they are irrevocable disclosed? --------
[AAG, par. 10.22]
E. Prepaid Health Care Services
1. Health Care Costs
a. Is the basis for accruing health care costs disclosed? --------
b. Are significant business and contractual arrangements with hospitals,
physicians, and other associated entities disclosed? --------
[SOP 89-5 (AAG, Appendix B), par. 32]
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2. Stop-Loss Insurance
a. Are receivables representing amounts recoverable from insurers reported as 
assets net of any valuation allowance?
b. Are the nature, amounts, and effects of significant stop-loss insurance 
contracts disclosed?
[SOP 89-5 (AAG, Appendix B), par. 49]
F. Other Disclosures
1. Are the nature and, if applicable, amount (or a statement that no loss estimate can 
be made) disclosed for loss contingencies (including guarantees)?
[SFAS 5, pars. 9—12 and FASBI 34, pars. 2—3 (AC C59.108—.114)]
2. Are gain contingencies adequately disclosed with care to avoid misleading 
implications as to the likelihood of realization?
[SFAS 5, par. 17 (AC C59.118)]
3. Are the nature, term, amount and other required information disclosed for long­
term unconditional purchase obligations?
[SFAS 47, pars. 7 and 10a (AC C32.102 and .105a)]
4. If an obligation for postemployment benefits (other than pensions) is not accrued 
in accordance with SFAS 5 (AC C59) or SFAS 43 (AC C44) only because the 
amount cannot reasonably be estimated and the financial statements are for a 
fiscal year beginning after December 15, 1993, is the fact of nonaccrual disclosed 
in the financial statements?
[SFAS 112, par. 7 (AC P32.105)]
VIII. Net Assets
A. Financial Statement Presentation
1. Are the equity accounts of investor-owned providers presented in a similar 
fashion as other investor-owned businesses?
[AAG, par. 11.01]
2. Are the net assets of not-for-profit and governmental providers (that use the 
disaggregated method) displayed as general and as restricted?
[AAG, par. 11.01]
3. Are the net assets of not-for-profit and governmental providers (that use the 
aggregated method) displayed as unrestricted, temporarily restricted or 
permanently restricted, as appropriate?
[AAG, par. 11.01]
4. Is the nature of restrictions on donor-restricted resources disclosed?
[AAG, par. 11.02]
5. Shareholders' Equity (Corporations)
a. Do the financial statements include a description, in summary form, sufficient 
to explain the pertinent rights and privileges of the various securities 
outstanding, (e.g., dividend and liquidation preferences, participation rights, 
call prices and dates, conversion or exercise prices or rates and pertinent 
dates, sinking fund requirements, unusual voting rights)?
[APB 15, par. 19 (AC E09.110)]
b. For preferred stock, do disclosures include:
(1) Aggregate or per share amounts at which shares may be called or are 
subject to redemption?
[APB 10, par. 11 (AC C16.102)]
(2) Aggregate and per share amounts of arrearages in cumulative preferred 
dividends?
[APB 15, par. 50, fn. 16 (AC C16.102)]
c. For stock option and stock purchase plans, do disclosures include:
(1) Number of shares under option?
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(2) Option price? _____
(3) Number of shares as to which options are exercisable? _____
(4) For options exercised, the number of shares involved and option price? _____
[ARB 43, Ch. 13B, par. 15 (AC C47.123)]
d. Are any appropriations of retained earnings for loss contingencies clearly
identified and included in stockholders' equity? _____
[SFAS 5, par. 15 (AC R70.103)]
e. Are restrictions on payment of dividends disclosed? _____
[SFAS 5, pars. 18—19 (AC C59.120)]
f. Are receivables for stock issued or subscribed appropriately identified and 
presented as a deduction from capital or, if presented as an asset, stated 
separately, clearly labeled, and their status clearly described to distinguish
them from any other type of assets? _____
g. Are the amounts of redemption requirements for all issues of capital stock 
that are redeemable at fixed or determinable prices on fixed or determinable 
dates disclosed for each of the five years following the date of the latest
balance sheet presented? --------
[SFAS 47, par. 10 (AC C32.105)]
6. Changes in Net Assets
a. When both financial position and results of operations are presented:
(1) Are changes in the separate component accounts of equity disclosed? --------
[APB 12, par. 10 (AC C08.102); AAG, par. 3.24]
(2) Are changes in the number of shares of capital stock disclosed for at least 
the latest year and any subsequent interim periods presented (for-profit
only)? --------
[APB 12, par. 10 (AC C08.102)]
b. Are prior-period adjustments and their resulting effects (both gross and net of
applicable income taxes) appropriately presented and disclosed? --------
[APB 9, par. 26 (AC A35.107)]
c. If an additional pension liability is required to be recognized and exceeds 
unrecognized prior service cost, is the excess (which would represent a net 
loss not yet recognized as net periodic pension cost) reported as a separate 
component (i.e., a reduction) of equity net of any tax benefits that result from
considering such losses as temporary differences? --------
[SFAS 87, par. 37 (AC P16.131)]
IX. Revenues, Expenses, Gains, and Losses
A. Conceptual Framework for Reporting and Classification
1. Are revenues and expenses (arising from ongoing activities associated with health
care services) classified as operating and displayed as gross amounts? --------
[AAG, par. 12.01]
2. Is display of gains and losses (resulting from peripheral or incidental transactions 
and from other events (environmentally related and largely uncontrollable)) as
net amounts considered? --------
[AAG, pars. 12.01—.02]
3. Are gains and losses classified in relation to major ongoing or central operations 
such as:
a. Operating, if related? --------
b. Nonoperating, if peripheral, incidental or unrelated? --------
[AAG, par. 12.03]
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4. For investments in common stock accounted for by the equity method, is the 
investor's share of earnings shown as a single amount except for investee 
extraordinary items and prior-period adjustments that are material to the
investor? _____
[APB 18, pars. 19c—d (AC I82.109c—d)]
5. Are total research and development costs charged to expenses disclosed for each
period for which a statement of revenues and expenses (operations) is presented? _____
[SFAS 2, pars. 12—13 (AC R50.108—.109); FASBI 4, par. 5 (AC B50.152); FASBI
6, par. 8 (AC R50.117); SFAS 68, par. 14 (AC R55.112); SFAS 86, par. 3 (AC 
Co2.102)]
6. Is the amount of interest cost incurred disclosed in the statements or notes 
thereto, and for an accounting period in which some interest cost is capitalized,
the total amount thereof that has been capitalized? _____
[SFAS 34, par. 21 (AC I67.118)]
7. If the provider accounts for its obligation under a research and development 
arrangement as a contract to perform research and development for others, is 
there disclosure of:
a. The terms of significant agreements under the research and development
arrangement as of the date of each balance sheet presented? _____
b. The amount of compensation earned or costs incurred under such contracts 
for each period for which a statement of revenues and expenses (statement of
operations) is presented? _____
[SFAS 68, par. 14 (AC R55.112)]
B. Revenue
1. Is revenue classified based on the type of service (such as patient or resident)
rendered or contracted to be rendered? _____
[AAG, par. 12.04]
2. Are contributions, tax support, and other subsidies classified as:
a. Gains, when peripheral or incidental to health care activities? _____
b. Revenues, if deemed ongoing major or central activities to provide health care
services? _____
[AAG, par. 12.05]
3. Is other revenue (such as from sales and services, other than health care, to 
patients, residents, nonpatients or visitors):
a. Classified as operating? _____
b. Stated separately? _____
[AAG, pars. 12.06—.07]
4. Are gains and losses properly classified and reported? _____
[AAG, par. 12.08]
C. Financial Statement Presentation (See Exhibit A)
1. Is service revenue reported net of contractual charity care and other adjustments? _____
[AAG, par. 12.11]
2. Do disclosures include the methods of:
a. Revenue recognition? _____
b. Recording unrestricted and restricted donations and investment income of
both general and restricted funds? _____
[AAG, par. 12.13]
3. With regard to contractual adjustments and third-party settlements, does the
provider identify and explain the estimated amounts payable or receivable? _____
[AAG, par. 12.13]
4. Are expenses incurred to solicit contributions separately disclosed? _____
[AAG, par. 12.16]
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No N/A
Yes No N/A
5. For each period for which an earnings statement is presented, are the following 
disclosures made:2
2 See footnote 1.
a. The proceeds from sales of available-for-sale securities and gross realized 
gains and losses on those sales?
b. The basis on which cost was determined in computing realized gain or loss 
(i.e., specified identification, average cost, or other method used)?
c. The gross gains and losses included in earnings from transfers of securities 
from the available-for-sale category to the trading category?
d. The change in net unrealized holding gain or loss on available-for-sale 
securities that is included in the separate component of shareholders' equity 
during the period?
e. The change in net unrealized holding gain or loss on trading securities that is 
included in earnings during the period?
[SFAS 115, par. 21 (AC I80.120)]
6. For any sales of or transfers from securities classified as held-to-maturity, are the 
following disclosed for each period for which an earnings statement is presented:
a. Amortized cost amount of the sold or transferred security?
b. Related realized or unrealized gain or loss?
c. The circumstances leading to the decision to sell or transfer the security? 
[SFAS 115, par. 22 (AC I80.114—.122)]
7. Income Taxes
a. Are the types of significant temporary differences and carryforwards 
disclosed?
[SFAS 109, par. 43 (AC 127.142)]
b. Are the following significant components of income tax expense attributable 
to continuing operations for each year presented disclosed in the financial 
statements or notes thereto:
(1) Current tax expense or benefit?
(2) Deferred tax expense or benefit (exclusive of the effects of other 
components listed below)?
(3) Investment tax credits?
(4) Government grants (to the extent recognized as a reduction of income tax 
expense)?
(5) The benefits of operating loss carryforwards?
(6) Tax expense that results from allocating certain benefits, either directly to 
contributed capital or to reduce goodwill or other noncurrent intangible 
assets of an acquired entity?
(7) Adjustments of a deferred tax liability or asset for enacted changes in tax 
laws or rates or a change in the tax status of the provider?
(8) Adjustments of the beginning-of-the-year balance of a valuation 
allowance because of a change in circumstances that causes a change in 
judgment about the realizability of the related deferred tax asset in future 
years?
[SFAS 109, par. 45 (AC I27.144)]
c. Is the amount of income tax expense or benefit allocated to continuing 
operations and the amounts separately allocated to other items disclosed for 
each year for which those items are presented?
[SFAS 109, pars. 35—39 and 46 (AC I27.134—.138 and .145)]
d. Is the nature of significant reconciling items disclosed?
[SFAS 109, par. 47 (AC I27.146)]
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e. Are the amounts and expiration dates of operating loss and tax credit 
carryforwards for tax purposes disclosed?
[SFAS 109, par. 48 (AC I27.147)]
f. If the provider is a member of a group that files a consolidated tax return, are 
the following items disclosed in its separately-issued financial statements:
(1) The aggregate amount of current and deferred tax expense for each period 
presented, and the amount of any tax-related balances due to or from 
affiliates as of the date of each balance sheet presented?
(2) The method by which the consolidated amount of current and deferred 
tax expense is allocated to members of the group and the nature and 
effect of any changes in that method (and in determining related balances 
to or from affiliates) for each period presented?
[SFAS 109, par. 49 (AC I27.148)]
8. Discontinued Operations
a. Are operations of a segment that are discontinued or are the subject of a 
formal plan for disposition:
(1) Reported separately from continuing operations and as a component 
(including applicable income taxes) of operations before extraordinary 
items?
(2) Accompanied by disclosure in the notes of revenue applicable to the 
discontinued operations?
[APB 30, par. 8 (AC I13.105)]
b. Is gain or loss from disposal of a discontinued segment reported separately
(including applicable income taxes) in conjunction with results of 
discontinued operations as a component of income before extraordinary 
items?
[APB 30, pars. 8, 13 and 15—18 (AC I13.101—.103, .105—.106 and .108— 
.109)]
c. For the period encompassing the measurement date, do notes to financial 
statement disclose:
(1) Identity of the segment discontinued?
(2) Expected disposal date, if known?
(3) Expected manner of disposal?
(4) Description of the remaining assets and liabilities of the discontinued 
segment at the balance-sheet date?
(5) Results of operations and any proceeds from disposal of the discontinued 
segment during the period from the measurement date to the balance- 
sheet date?
[APB 30, par. 18 (AC I13.108—.109)]
d. For periods after the measurement date and including the disposal, do notes 
to financial statements disclose the information required for the period 
encompassing the measurement date and the actual date and results of 
disposal compared with the prior estimates?
[APB 30, par. 18 (AC I13.108—.109)]
9. Extraordinary Items
a. Are extraordinary items segregated and shown (including applicable income 
taxes) after income before extraordinary items and before net income?
[APB 30, par. 10—12 (AC I17.102—.103)]
b. Are descriptive captions and amounts (including applicable income taxes) 
presented for individual extraordinary events or transactions, preferably on 
the face of the income statement, if practicable?
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c. Do disclosures include descriptions of extraordinary events or transactions 
and the principal items entering into determination of extraordinary gains or
losses? _____
[APB 30, par. 11 (AC I17.102)]
d. For gains or losses from extinguishment of debt classified as extraordinary 
items, do disclosures include:
(1) Description of the extinguishment transactions, including the sources of
any funds used to extinguish the debt if it is practicable to identify the 
sources? _____
(2) Income tax effect in the period of extinguishment? _____
(3) Per share amount (if applicable) of the aggregate gain or loss net of
related income tax effect? _____
[SFAS 4, pars. 8—10 (AC I17.104 and D14.105—.107)]
e. For an adjustment of an extraordinary item reported in a prior period (except 
for correction of an error):
(1) Is the adjustment classified separately as an extraordinary item in the
current period? --------
(2) Are the nature, origin, and amount of the item disclosed? --------
[SFAS 16, par. 16(c) (AC I17.119)]
10. Are material events or transactions that are either unusual in nature or of 
infrequent occurrence, but not both (and therefore not meeting criteria for 
extraordinary items):
a. Reported as a separate component of income from continuing operations? --------
b. Accompanied by disclosure of the nature and financial effects of each event? --------
[APB 30, par. 26 (AC I22.101)]
11. Do disclosures for advertising costs include:
a. The accounting policy selected from the two alternatives in the beginning of 
paragraph 26 of SOP 93-7 for reporting advertising, indicating whether such
costs are expensed as incurred or the first time the advertising takes place? --------
b. A description of the direct-response advertising reported as assets (if any), the
accounting policy for it, and the amortization period? --------
c. The total amount charged to advertising expense for each income statement
presented, with separate disclosure of amounts, if any, representing a write­
down to net realizable value? --------
d. The total amount of advertising reported as assets in each balance sheet
presented? --------
[SOP 93-7, par. 49]
X. Statement of Cash Flows
A. Is a statement of cash flows presented as a basic financial statement for each 
period for which a statement of revenues and expenses (statement of operations) 
is presented for:
1. General funds of a nonprofit or governmental entity? --------
2. Restricted funds of a governmental entity? --------
3. Any investor-owned entity? --------
[SFAS 95, par. 3 (AC C25.101); AAG, pars. 3.24—.25]
B. Does the statement of cash flows show the change in cash and cash equivalents? --------
[SFAS 95, par. 7 (AC C25.105)]
C. Is the policy for defining cash equivalents disclosed? --------
[SFAS 95, par. 10 (AC C25.108)]
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D. If the direct method is used, is a reconciliation of the excess of revenues and 
expenses (income) to net cash flow from operating activities provided in a 
separate schedule?
[SFAS 95, par. 30 (AC C25.128)]
E. If the indirect method is used:
1. Is the same amount for net cash flow from operating activities reported indirectly 
by adjusting the excess of revenues and expenses (income) to reconcile it to net 
cash flow from operating activities?
[SFAS 95, par. 28 (AC C25.126)]
2. Is the reconciliation of the excess of revenues and expenses (income) to net cash 
flow from operating activities reported, either within the statement of cash flows 
or provided in a separate schedule, with the statement of cash flows reporting 
only the net cash flow from operating activities?
[SFAS 95, par. 30 (AC C25.128)]
F. Are cash receipts and cash payments for the following transactions classified as 
cash flows from operating activities:
1. Interest received on loans?
2. Insurance proceeds except those directly related to investing or financing 
activities?
3. Interest paid to creditors?
4. Payments to suppliers and employees?
5. Payments to governments for taxes, duties, fines, and other fees or penalties?
6. Payments to settle lawsuits?
7. Contributions to charities?
[SFAS 95, pars. 22—23 (AC C25.120—.121)]
G. Are cash receipts and cash payments for the following transactions classified as 
cash flows from investing activities:
1. Receipts from collections or sales of loans?
2. Receipts from sales of property?
3. Loans to others?
4. Payments to acquire property?
[SFAS 95, pars. 16—17 (AC C25.114—.115)]
H. Are cash receipts and cash payments for the following transactions classified as 
cash flows from financing activities:
1. Proceeds from issuing debt?
2. Repayments for amounts borrowed?
[SFAS 95, pars. 19—20 (AC C25.117—.118)]
I. Except for certain items whose turnover is quick, amounts are large and maturities 
are short, are cash receipts and cash payments from investing and financing 
activities shown separately on the statement of cash flows?
[SFAS 95, pars. 12—13 and 31 (AC C25.110—.111 and .129)]
J. Are noncash investing and financing activities (such as converting debt to equity) 
summarized in a separate schedule or the notes?
[SFAS 95, par. 32 (AC C25.134)]
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XI. Related Organizations and Economic Dependency
A. Consolidation and Combination (See Exhibit A)
1. If the provider and another entity are related and they meet the criteria for 
consolidation or combination (“consolidation"), are consolidated or combined
("consolidate") financial statements presented? _____
[AAG, par. 13.02; ARB 51 (AC C51); SFAS 94 (AC C51)]
2. If consolidated statements are presented:
a. Is the consolidation policy disclosed? _____
[ARB 51, par. 5 (AC C51.108); APB 22, par. 13 (AC A10.106)]
b. When the financial reporting periods of consolidated entities differ, is 
recognition given, by disclosure or otherwise, to the effect of intervening
events that materially affect financial position or results of operations? _____
[ARB 51, par. 04 (AC C51.107); FASBI 13, pars. 6—8 (AC I89.120—.122)]
3. Do disclosures about formerly unconsolidated subsidiaries that are now 
consolidated include summarized information about the assets, liabilities, and 
results of operations (or separate statements) in the consolidated financial
statements or notes? --------
[AAG, par. 13.02; SFAS 94, par. 14 (AC C51.120A)]
B. Related Parties and Economic Dependency
1. If the entity does not meet the criteria for consolidation or combination, but 
controls and is the sole beneficiary of a related organization's activities, is
summarized financial data of the related organization disclosed? _____
[AAG, pars. 13.03—.04]
2. For any related party that is not consolidated or combined, does the entity 
disclose (even if there are no transactions between them):
a. The nature of the relationship between the entity and the related party? --------
b. If there are material transactions between the entity and the related party:
(1) A description of the transactions, including transactions to which nominal
or no amounts were ascribed? --------
(2) The amount of such transactions? --------
(3) Amounts due from or to the related party and, if not apparent, the terms
and manner of settlement? --------
[AAG, par. 13.05; SFAS 13, par. 29 (AC L10.125); SFAS 57, pars. 2—4 
(AC R36.102—.104)]
XII. Continuing Care Retirement Communities (CCRCs)
A. Refundable Advance Fees
1. Is the estimated amount of advance fees expected to be refunded to current
residents reported as a liability? --------
[SOP 90-8 (AAG, Appendix C), par. 22]
2. Is the remaining amount of advance fees reported in the balance sheet as deferred
revenue? --------
[SOP 90-8 (AAG Appendix C), par. 22]
3. Are the following disclosed:
a. The gross amount of contractual refund obligations under existing contracts? --------
b. The CCRC's refund policy? --------
[SOP 90-8 (AAG, Appendix C), par. 22]
4. Are amounts refunded disclosed in the statement of cash flows as a financing
transaction? --------
[SOP 90-8 (AAG, Appendix C), par. 22]
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5. Is the method of accounting, including the amortization method, for deferred 
revenue disclosed?
[AAG, par. 9.34; SOP 90-8 (AAG, Appendix C), pars. 23, 31 and 43]
B. Fees Refundable to Residents Only From Reoccupancy Proceeds of a Contract 
Holder's Unit
1. Are the following reported as deferred revenue:
a. The portion of fees to be paid to current residents or their designees, only to 
the extent of a contract holder's unit reoccupancy proceeds, if law and 
management policy and practice support the withholding of refunds under 
this condition?
b. Similar amounts received from new residents in excess of the amount to be 
paid to previous residents or their designees?
[SOP 90-8 (AAG, Appendix C), par. 31]
C. Nonrefundable Advance Fees
1. Are nonrefundable advance fees reported as deferred revenue?
[SOP 90-8 (AAG, Appendix C), par. 43]
2. Is unamortized deferred revenue reported as revenue upon a resident's death or 
contract termination?
[SOP 90-8 (AAG, Appendix C), pars. 23 and 43]
D. Obligation to Provide Future Services and Use of Facilities to Current
Residents
1. If the obligation to provide future services and use of facilities to current residents 
under continuing-care contracts results in a liability, are the following disclosed:
a. The carrying amount of the liability?
b. The interest rate used to discount that liability?
[SOP 90-8 (AAG, Appendix C), par. 55]
E. Costs of Acquiring Initial Continuing-Care Contracts
1. Are costs of acquiring initial continuing-care contracts capitalized if they are 
expected to be recovered from future contract revenues?
[SOP 90-8 (AAG, Appendix C), par. 63]
2. Are continuing-care contract acquisition costs expensed if incurred after (a) the 
CCRC is substantially occupied or (b) one year following completion?
[SOP 90-8 (AAG, Appendix C), par. 63]
XIII. Financial Statements and Notes—General
A. Titles and References
1. Are the financial statements suitably titled?
[SAS 62, par. 7 (AU 623.07)]
2. Does each statement include a general reference that the notes are an integral 
part of the financial statement presentation?
B. Disclosure of Accounting Policies
1. Is a description of all pertinent accounting policies of the provider presented as an 
integral part of the financial statements?
[APB 22, pars. 8—9 (AC A10.102—.103)]
2. Does disclosure of significant accounting policies encompass important 
judgments as to the appropriateness of principles concerning recognition of 
revenue and allocation of asset costs to current and future periods?
[APB 22, par. 12 (AC A10.105)]
3. Does disclosure of significant accounting policies include appropriate reference to 
details presented elsewhere (in the statements and notes thereto) so duplication 
of details is avoided?
[APB 22, par. 14 (AC A10.107)]
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C. Accounting Changes
1. For an accounting change, does disclosure in the period of the change include:
a. Nature of the change? _____
b. Justification for the change, including a clear explanation of why the newly
adopted principle is preferable? _____
c. Effect on income? _____
[APB 20, par. 17 (AC A06.113)]
2. For changes in accounting principle (excluding specific exceptions related to an 
initial public offering, change in the reporting entity, or adoption of certain 
authoritative pronouncements):
a. If comparative financial statements are included, are they presented as
previously reported? _____
b. Is the cumulative effect of the change (direct effects and income tax effects
only) on beginning retained earnings for the period of the change shown in 
the statement of revenues and expenses (statement of operations) of that 
period, after any extraordinary items and before net revenue and gains in 
excess of expenses and losses (net income)? _____
c. Is the effect of adopting the new accounting principle on revenue and gains in
excess of expenses and losses (income) before extraordinary items and net 
revenue and gains in excess of expenses and losses (net income) (and 
applicable per share data) disclosed for the period of the change? _____
d. Are pro forma revenues and gains in excess of expenses and loss (income)
before extraordinary items and net revenue and gains in excess of expenses 
and losses (net income) shown on the face of the statement of revenue and 
expenses (statement of operations) for all periods presented as if the newly 
adopted accounting principle had been applied during all periods affected? _____
e. If pro forma amounts or cumulative effects cannot be determined, are the
reasons disclosed? _____
[APB 20, pars. 12, 17—22, 24—26, 29 and 34 (AC A06.113—.118, .120—.122
and .125, and A35.112 and .114); FASBI 20, par. 5 (A06.127)]
3. Is the correction of an error shown as a prior-period adjustment with disclosure of 
the following in the period of its discovery and correction:
a. Nature of the error in previously issued financial statements? _____
b. Effect of its correction on revenue and gains in excess of expenses and losses 
(income) before extraordinary items and net revenue and gains in excess of 
expenses and losses (net income) (and related per share amounts if
applicable)? --------
[APB 20, par. 36 (AC A35.105); SFAS 109, par. 288n (AC A35.103)]
D. Financial Instruments
1. Except for certain excluded items (SFAS 105, pars. 14—15 (AC F25.104—.105)), 
are the following disclosed in the financial statements or notes for each class of 
financial instruments with off-balance-sheet risk:
a. The face or contract amount, or notional principal amount if there is no face
or contract amount? --------
b. The nature and terms, including, at a minimum, a discussion of:
(1) Credit and market risk of those instruments? --------
(2) Cash requirements of those instruments? _____
(3) Related accounting policy, as required by APB 22, Disclosure of
Accounting Policies (AC A10)? --------
[SFAS 105, par. 17 (CT F25.112)]
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2. For financial instruments with off-balance-sheet credit risk (except for the items 
excluded in SFAS 105 (AC F25)), are the following disclosed, either in the 
financial statements or in the notes, by class of financial instrument:
a. The amount of accounting loss the entity would incur if any party to the
financial instrument failed completely to perform according to the terms of 
the contract and if the collateral or other security, if any, for the amount due 
proved to be of no value to the entity? _____
b. Regarding collateral or other security to support financial instruments subject 
to credit risk:
(1) The entity's policy of requiring such collateral or other security? _____
(2) Information about the entity's access to that collateral or other security? _____
(3) The nature and a brief description of the collateral or other security
supporting those financial instruments? _____
[SFAS 105, par. 18 (AC F25.113)]
3. Do disclosures of all significant concentrations of credit risk arising from all 
financial instruments, whether from an individual counterparty or groups of 
counterparties (except for certain insurance and investment contracts, purchase 
and pension obligations and substantively extinguished debt), include:
a. Information about the (shared) activity, region, or economic characteristic that
identifies the concentration? _____
b. The amount of the accounting loss due to credit risk the entity would incur if 
any party to the financial instruments that make up the concentration failed 
completely to perform according to the terms of the contracts and if the 
collateral or other security, if any, for the amount due proved to be of no
value to the entity? _____
c. Regarding collateral or other security to support financial instruments subject 
to credit risk:
(1) The entity's policy of requiring such collateral or other security? _____
(2) Information about the entity's access to that collateral or other security? _____
(3) The nature and a brief description of the collateral or other security
supporting those financial instruments? _____
[SFAS 105, pars. 14 and 20 (AC F25.104 and .115)]
4. Is the fair value of financial instruments for which it is practicable to estimate that 
value (except for certain excluded items and trade receivables and payables 
whose amount approximates fair value) disclosed in the financial statements or
accompanying notes? _____
[SFAS 107, par. 10, as amended by SFAS 119, par. 15 (AC F25.115C)]
5. Are the methods and significant assumptions used to estimate the fair value of
financial instruments disclosed? _____
[SFAS 107, par. 10 (AC F25.115C)]
6. If it is not practicable to estimate the fair value of a financial instrument, are the 
following disclosed:
a. Information pertinent to estimating the fair value of that financial instrument
or class of financial instruments, such as the carrying amount, effective 
interest rate, and maturity? _____
b. The reasons why it is not practicable to estimate fair value? _____
[SFAS 107, par. 14 (AC F25.115G)]
E. Nonmonetary Transactions
1. Do disclosures include:
a. Nature of the transactions? _____
b. Basis of accounting for the assets transferred? _____
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c. Gains or losses recognized on the transfers?
[APB 29, par. 28 (AC Cl 1.102 and N35.120)]
F. Subsequent Events
1. Are the financial statements adjusted for any changes in estimates resulting from 
subsequent events that provide additional evidence about conditions that existed 
at the balance-sheet date?
[SFAS 5, par. 8 (AC C59.105); SAS 1, secs. 560.03—.04, .07 and 561.01—.09 (AU 
560.03—.04, .07 and 561.01—.09)]
2. Are subsequent events that provide evidence about conditions that did not exist 
at the date of the balance sheet, but arose subsequent to that date, adequately 
disclosed to keep the financial statements from being misleading?
[SFAS 5, par. 11 (AC C59.112); APB 16 (AC B50.120); SAS 1, secs. 560.05—. 07, 
.09 and 561.01—.09 (AU 560.05—.07, .09 and 561.01—.09)]
G. Pension Plans
1. If there is a defined benefit plan, do disclosures include:
a. A description of the plan, including employee groups covered, type of benefit 
formula, funding policy, types of assets held and significant nonbenefit 
liabilities, if any, and the nature and effect of significant matters affecting 
comparability of information for all periods presented?
b. The amount of net periodic pension cost for the period showing separately 
the service cost component, the interest cost component, the actual return on 
assets for the period, and the net total of other components?
c. A schedule reconciling the funded status of the plan with amounts reported in 
the employer's balance sheet, showing separately:
(1) The fair value of plan assets?
(2) The projected benefit obligation identifying the accumulated benefit 
obligation and the vested benefit obligation?
(3) The amount of unrecognized prior-service cost?
(4) The amount of unrecognized net gain or loss (including asset gains and 
losses not yet reflected in market-related value)?
(5) The amount of any remaining unrecognized net obligation or net asset 
existing at the date of initial application of SFAS 87 (AC Pl6)?
(6) The amount of any additional liability recognized pursuant to SFAS 87, 
paragraph 36 (AC P16.130)?
(7) The amount of net pension asset or liability recognized in the balance 
sheet pursuant to SFAS 87, paragraphs 35—36 (AC P16.129—.130) 
(which is the net result of combining the preceding six items)?
d. The weighted-average assumed discount rate and rate of compensation 
increase (if applicable) used to measure the projected benefit obligation and 
the weighted-average expected long-term rate of return on plan assets?
e. If applicable, the amount and types of securities of the employer and related 
parties included in plan assets and the approximate amount of annual 
benefits of employees and retirees covered by annuity contracts issued by the 
employer and related parties (also, if applicable, the alternative amortization 
methods used pursuant to SFAS 87, paragraphs 26 and 33 (AC P16.120 and 
.127), and the existence and nature of the commitment discussed in paragraph 
41 (AC P16.135))?
[SFAS 87, par. 54 (AC P16.150)]
f. If more than one defined benefit plan exists:
(1) Are the disclosures required by Step G.1. above aggregated for all of the 
employee's single-employer defined benefit plans or disaggregated in 
groups so as to provide the most useful information?
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(2) Are plans with assets in excess of accumulated benefit obligations not 
aggregated with plans that have accumulated benefit obligations that 
exceed plan assets?
[SFAS 87, par. 56 (AC P16.153)]
2. If there are one or more defined contribution plans, do disclosures include:
a. A description of the plans, including employee groups covered, the basis for 
determining contributions, and the nature and effect of significant matters 
affecting comparability of information for all periods presented?
b. The amount of cost recognized during the period?
[SFAS 87, par. 65 (AC P16.162)]
3. If the substance of a plan having characteristics of both defined benefits and 
contributions is to provide a defined benefit, are disclosures in accordance with 
the requirements applicable to a defined benefit plan as described in Step G.1. 
above?
[SFAS 87, par. 66 (AC P16.163)]
4. If there are one or more multiemployer plans, do disclosures include:
a. A description of the multiemployer plans, including the employee groups 
covered, the type of benefits provided (defined benefit or defined 
contribution), and the nature and effect of significant matters affecting 
comparability of information for all periods presented?
b. The amount of cost recognized during the period?
[SFAS 87, par. 69 (AC P16.166)]
5. If there is a settlement and/or curtailment of a defined benefit pension plan and/ 
or termination of benefits under such plan, do disclosures include:
a. A description of the nature of the event(s)?
b. The amount of gain or loss recognized?
[SFAS 88, par. 17 (AC P16.187)]
H. Postretirement Benefits Other Than Pensions
1. If there are one or more defined benefit postretirement plans, do disclosures 
include:
a. A description of the substantive plans that is the basis for the accounting for 
the postretirement benefits, including the nature of the plans, any 
modifications of the existing cost-sharing provisions that are encompassed by 
the substantive plans, and the existence and nature of any commitment to 
increase monetary benefits provided by the plans, employee groups covered, 
types of benefits provided, funding policy, types of assets held and significant 
nonbenefit liabilities, and the nature and effect of significant matters affecting 
the comparability of information for all periods presented, such as the effect 
of a business combination or divestiture?
b. The amount of net periodic postretirement benefit cost showing separately 
the service cost component, the interest cost component, the actual return on 
plan assets for the period, amortization of the unrecognized transition 
obligation or transition asset, and the net total of other components?
c. A schedule reconciling the funded status of the plans with amounts reported 
in the employer's balance sheet, showing separately:
(1) The fair value of plan assets?
(2) The accumulated postretirement benefit obligation, identifying separately 
the portion attributable to retirees, other fully eligible plan participants, 
and other active plan participants?
(3) The amount of unrecognized prior-service cost?
(4) The amount of unrecognized net gain or loss (including plan asset gains 
and losses not yet reflected in market-related value)?
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(5) The amount of any remaining unrecognized transition obligation or 
transition asset?
(6) The amount of net postretirement benefit asset or liability recognized in 
the balance sheet, which is the net result of combining the preceding five 
items?
d. The assumed health care cost trend rate(s) used to measure the expected cost 
of benefits covered by the plan (gross eligible changes) for the next year and a 
general description of the direction and pattern of change in the assumed 
trend rate(s) thereafter, together with the ultimate trend rate(s) and when the 
rate(s) is expected to be achieved?
e. The weighted average of the assumed discount rate(s) and rate(s) of 
compensation increase (for pay-related plans) used to measure the 
accumulated postretirement benefit obligation and the weighted average of 
the expected long-term rate(s) of return on plan assets and, for plans whose 
income is segregated from the employer's investment income for tax 
purposes, the estimated income tax rate(s) included in that rate of return?
f. The effect of a one-percentage-point increase in the assumed health care cost 
trend rates for each future year on:
(1) The aggregate of the service and interest cost components of net periodic 
postretirement health care benefit cost?
(2) The accumulated postretirement benefit obligation for health care benefits 
(for purposes of this disclosure, all other assumptions shall be held 
constant and the effects shall be measured based on the substantive plan 
that is the basis for the accounting)?
g. The amounts and types of securities of the employer and related parties 
included in plan assets, and the approximate amount of future annual benefits 
of plan participants covered by insurance contracts issued by the employer 
and related parties?
h. Any alternative amortization method used?
i. The amount of gain or loss recognized during the period for a settlement or 
curtailment and a description of the nature of the event(s)?
j. The cost of providing special or contractual termination benefits recognized 
during the period and a description of the nature of the event(s)?
[SFAS 106, par. 74 (AC P40.169)]
2. If more than one defined benefit postretirement plan exists:
a. Are the disclosures aggregated for all of an employer's single-employer 
defined benefit postretirement plans or disaggregated in groups so as to 
provide the most useful information (except that the aggregate plan assets 
and the aggregate accumulated postretirement benefit obligation of the 
underfunded plans should be separately disclosed)?
[SFAS 106, par. 77 (AC P40.172)]
b. Are plans that primarily provide postretirement health care benefits and plans 
that primarily provide other postretirement welfare benefits separately 
disclosed if the accumulated postretirement benefit obligation of the latter 
plans is significant relative to the aggregate accumulated postretirement 
benefit obligation for all of the plans?
[SFAS 106, par. 78 (AC P40.173)]
3. If there is a multiemployer plan, do disclosures include:
a. A description of the multiemployer plan(s), including the employee groups 
covered, the type of benefits provided (defined benefit or defined 
contribution), and the nature and effect of significant matters affecting 
comparability of information for all periods presented?
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b. The amount of postretirement benefit cost recognized during the period, if 
available (otherwise, the amount of the aggregate required contribution for 
the period to the general health and welfare benefit plan that provides health 
and welfare benefits to both active employees and retirees)?
[SFAS 106, par. 82 (AC P40.178)]
4. If there are one or more defined contribution postretirement plans, are the 
following items disclosed separately from defined benefit postretirement plan 
information:
a. A description of the plan(s), including employee groups covered, the basis for 
determining contributions, and the nature and effect of significant matters 
affecting comparability of information for all periods presented?
b. The amount of cost recognized during the period?
[SFAS 106, par. 106 (AC P40.198)]
I. Lessor Leases
1. For sales-type and direct financing leases, do disclosures include:
a. Appropriate components of the net investment in the leases as of the date of 
each balance sheet presented?
b. Future minimum lease payments to be received for each of the five 
succeeding fiscal years as of the latest balance-sheet date presented?
c. Total contingent rentals included in income for each period for which an 
income statement is presented?
[SFAS 13, par. 23a (AC L10.119a)]
d. For direct financing leases, the amount of initial direct costs as part of the 
investment?
[SFAS 91, par. 25d (AC L10.119(a)(1))]
2. For operating leases, do disclosures include:
a. Cost and carrying amount of property on lease or held for leasing by major 
classes and the amount of accumulated depreciation as of the date of the 
latest balance sheet presented?
b. Minimum future rentals on noncancelable leases as of the date of the latest 
balance sheet presented in the aggregate and for each of the five succeeding 
fiscal years?
c. Total contingent rentals included in income for each period for which an 
income statement is presented?
[SFAS 13, par. 23b (AC L10.119b)]
J. Lessee Leases
1. For capital leases do disclosures include:
a. Gross amounts of assets recorded by major classes, as of the date of each 
balance sheet presented?
b. Future minimum lease payments, as of the date of the latest balance sheet 
presented, in total and for each of the next five years, with separate 
deductions for executory costs and imputed interest to reduce net minimum 
lease payments to present value?
c. Total future minimum sublease rentals under noncancelable subleases as of 
the date of the latest balance sheet presented?
d. Total contingent rentals actually incurred for each period presented?
e. Assets recorded under capital leases and the related accumulated 
amortization, and obligations under those leases identified separately in the 
balance sheet or a note?
[SFAS 13, pars. 13 and 16 (AC L10.112a)]
30
No N/A
Yes
2. For operating leases that have initial or remaining noncancelable lease terms in 
excess of one year, do disclosures include:
a. Future minimum rental payments required as of the latest balance sheet 
presented in total and for each of the next five years?
b. Total future minimum rentals under noncancelable subleases as of the date of 
the latest balance sheet presented?
[SFAS 13, par. 16b (AC L10.112b)]
3. For all operating leases do disclosures include rental expense for each period 
presented, with separate amounts for minimum rentals, contingent rentals, and 
sublease rentals?
[SFAS 13, par. 16c (AC L10.112c)]
4. Do disclosures include a general description of the lessee's leasing arrangements 
including, but not limited to:
a. Bases for determination of contingent rentals?
b. Terms of any renewal or purchase options or escalation clauses?
c. Restrictive covenants?
[SFAS 13, par. 16d (AC L10.112d)]
K. Other Liabilities and Deferred Credits
1. If the entity is subject to income taxes:
a. Are deferred tax liabilities classified as current or noncurrent based on the 
related asset or liability for financial reporting?
[SFAS 109, par. 41 (AC I27.140)]
b. Are deferred tax liabilities not related to an asset or liability for financial 
reporting classified according to the expected reversal date of the temporary 
difference pursuant to SFAS 37?
[SFAS 109, par. 41 (AC I27.140)]
c. Are the following items offset and presented as a single amount for a 
particular tax-paying component and within a particular tax-paying 
jurisdiction:
(1) All current deferred tax liabilities and assets?
(2) All noncurrent deferred tax liabilities and assets?
[SFAS 109, par. 42 (AC I27.141)]
d. Are the components of the total of all deferred tax liabilities recognized in the 
balance sheet disclosed?
[SFAS 109, par. 43 (AC I27.142)]
L. Risks and Uncertainties (SOP 94-6, Disclosure of Certain Significant Risks and
Uncertainties, is effective for financial statements issued for fiscal years ending 
after December 15, 1995, and for financial statements for interim periods in fiscal 
years subsequent to the year for which this SOP is to be first applied. Early 
application is encouraged but not required.)
1. 1. Are the following disclosed?
a. The nature of the provider's operations?
b. The fact that financial statements prepared in accordance with GAAP require 
the use of management's estimates.
[SOP 94-6, pars. 10 and 11]
2. If (a) it is at least reasonably possible that the estimate(s) used in preparing the 
financial statements will change in the near term, and (2) the effect(s) of the 
change will be material, are the following disclosed?
a. The nature of uncertainties inherent in estimates used to determine the 
carrying amounts of assets and liabilities, or used to disclose gain or loss 
contingencies.
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b. That a material change in the estimate could occur in the near term.
[SOP 94-6, pars. 12-14]
3. If (a) concentrations exist at the financial statement date, and (b) the 
concentrations could cause the provider a near-term severe impact, are the 
following disclosed?
a. Concentrations in the volume of business transacted with a particular 
customer (patient), supplier, lender, grantor, or contributor.
b. Concentrations in revenue from particular services provided or fund-raising 
events.
c. Concentrations in the available sources of supply of labor, services, or of 
applicable licenses necessary to provide services.
d. Concentrations in the market or geographical area in which an entity 
conducts its operations, including the carrying amounts of net assets and their 
locations.
e. Concentrations of labor subject to collective bargaining agreements, including 
the percentage of the labor force covered by a collective bargaining agreement 
and the percentage of the labor force covered by a collective bargaining 
agreement that will expire within one year.
f. Information adequate to inform users of the general nature of the risk 
associated with the concentration.
[SOP 94-6, pars. 21-24]
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Exhibit A—Various
SFAS 115 applies to for-profit entities only. The effective date of SFAS 115 is for fiscal 
years beginning after December 15, 1993. It is to be initially applied as of the 
beginning of a fiscal year and cannot be applied retroactively to prior years' financial 
statements. A for-profit entity may elect to apply this statement as of the end of an 
earlier fiscal year for which annual financial statements have not previously been 
issued. Until such applications, and for not-for-profit entities, the following 
disclosures remain in effect:
A. Consolidations and Combination
1. If the parent company includes realized gains or losses of marketable securities in 
net income and a consolidated subsidiary does not, is the subsidiary's accounting 
treatment for marketable securities conformed with that of the parent?
[SFAS 12, par. 18 (AC I89.112)]
2. If the parent follows specialized accounting practices for marketable securities 
and the consolidated subsidiaries do not, are the subsidiaries' current and 
noncurrent portfolios consolidated as separate current and noncurrent portfolios 
exclusive of the parent and is the information required by SFAS 12, paragraph 12, 
disclosed?
[SFAS 12, pars. 12 and 19 (AC I89.106 and .113)]
3. If the consolidated financial statements include more than one accepted practice 
of accounting for marketable securities, are the required disclosures for the 
various methods disclosed?
[SFAS 12, par. 20 (AC I89.114)]
B. Marketable Equity Securities
1. For marketable equity securities, do disclosures include:
a. For each balance sheet presented, aggregate cost and market value (each 
segregated between current and noncurrent portfolios when a classified 
balance sheet is presented) with identification as to which is the carrying 
amount?
b. For the latest balance sheet presented, gross unrealized gains and gross 
unrealized losses (each segregated between current and noncurrent portfolios 
when applicable)?
[SFAS 12, pars. 12b and 16a (AC I89.106b and .110a)]
c. For each period for which a statement of revenues and expenses (statement of 
operations) is presented:
(1) Net realized gain or loss included in the statement?
(2) Basis on which cost was determined in calculating realized gain or loss 
(such as average cost or FIFO)?
[AAG, par. 6.09; SFAS 12, pars. 12 and 16 (AC I89.106 and .110)]
2. Are significant net realized and net unrealized gains and losses that arose after 
the latest balance sheet date, but before issuance of the financial statements, 
disclosed?
[AAG, par. 6.10; SAS 1, sec. 560, pars. 5 and 7 (AU 560.05 and .07); SFAS 12, 
pars. 13 and 17 (AC I89.107 and .111); FASBI 11, pars. 3—4 (AC I89.115—.116); 
FASBI 13, pars. 5—7 (AC I89.120—.122)]
3. Are losses due to a change in classification of a marketable equity security 
between current and noncurrent reported in the statement of revenues ana 
expenses?
[AAG, par. 6.12; SFAS 12, par. 10 (AC I89.104)]
4. For a portfolio included in current assets in the general funds, are changes in the 
valuation allowance disclosed and reported in the statement of revenues and 
expenses?
[AAG, par. 6.12]
5. For a portfolio included in noncurrent assets, or assets in unclassified balance
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sheets or restricted funds, are changes in the valuation allowance disclosed and
reported in the respective statement of changes in fund balances or equity? ____
[AAG, par. 6.12; SFAS 12, par. 11 (AC I89.105)]
C. Financial Statement Presentation
1. For marketable equity securities, are the following disclosed for each period for 
which an income statement is presented:
a. Net realized gain or loss included in determination of net income? ____
[SFAS 12, par. 12c (AC I89.106c)]
b. For entities with certain specialized accounting practices, the change in net
unrealized gain or loss? ____
[SFAS 12, par. 16b (AC I89.110b)]
c. Basis on which cost was determined in computing realized gain or loss? ____
[SFAS 12, par. 12c (AC I89.106c)]
d. The change in valuation allowance(s) during the period and when a classified 
balance sheet is presented and the amount of such change included in the
determination of net income? ____
[SFAS 12, par. 12c (AC I89.106c)]
Exhibit B—SFAS 116 and 117
In June 1993, the FASB issued SFAS 116, Accounting for Contributions Received and 
Contributions Made, (applies to both for-profit and not-for-profit health care 
providers) and SFAS 117, Financial Statements of Not-for-Profit Organizations. Both 
Statements are effective for annual financial statements issued for fiscal years 
beginning after December 15, 1994, except for organizations with less than $5 million 
in total assets and less than $1 million in annual expenses. For those organizations, 
the Statements are effective for fiscal years beginning after December 15, 1995. For 
providers implementing those pronouncements, the following items should be 
considered in addition to other appropriate inquiries contained in this checklist:
A. Contributions Received
1. If the provider receives contributed services, does it disclose the following?:
a. A description of the programs or activities for which those services were used, 
including the nature and extent of contributed services received for the period
and the amount recognized as revenues for the period? ____
b. The fair value of contributed services received but not recognized, if
practicable (optional)? ____
c. Nonmonetary information such as the number and trends of donated hours
received or service outputs provided by volunteer efforts (optional)? ____
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d. Dollar amount of contributions raised by volunteers (optional)?
[SFAS 116, pars. 10 and 123 (AC C67.110)]
2. Does the provider distinguish between contributions received with permanent 
restrictions, those received with temporary restrictions, and those received 
without donor-imposed restrictions, so that they are reported as support 
increasing permanently restricted net assets, temporarily restricted net assets, or 
unrestricted net assets, respectively?
[SFAS 116, par. 14 (AC No5.143)
3. If donor-restricted contributions whose restrictions are met in the same reporting 
period are reported as unrestricted support, is such treatment consistent from 
period to period and is the policy disclosed?
[SFAS 117, par. 21; SFAS 116, par. 14 (AC No5.143)
4. Does the provider report receipt of unconditional promises to give with payments 
due in future periods as restricted support, unless explicit donor stipulations or 
circumstances surrounding the receipt of the promise make clear that the donor 
intended the contribution to be used to support activities of the current period?
[SFAS 116, par. 15 (AC No5.144)]
5. Does a provider that receives gifts of long-lived assets without donor stipulation 
about how long the donated asset must be used:
a. Disclose its accounting policy of implying or not implying a time restriction
that expires over the useful life of the asset? _____
b. Report such support as restricted if it is the organization's policy to imply a
time restriction that expires over the useful life of the donated asset? _____
c. Report such support as unrestricted in the absence of such a policy?
[SFAS 116, par. 16 (AC No5.145)]
6. Contributions Made
1. Does a provider that receives promises to give in which the assets promised 
will be received in future periods report subsequent accruals of the interest 
element as contribution income increasing either the temporarily or 
permanently restricted class of net assets if the underlying promise to give is 
donor restricted?
[SFAS 116, par. 20 (AC C67.116)]
2. Do providers that receive unconditional promises to give disclose the 
following:
a. The amounts of promises receivable in less than one year, in one to five years,
and in more than five years? _____
b. The amount of any allowance for uncollectible promises receivable?
[SFAS 116, par. 24 (AC C67.121)]
3. Do providers that receive conditional promises to give disclose the following:
a. The total of the amounts promised? _____
b. A description and amount for each group of promises having similar 
characteristics (such as amount of promises conditioned on establishing new 
programs, completing a new building, and raising matching gifts by a 
specified date)?
[SFAS 116, par. 25 (AC C67.122)]
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C. Financial Statement Presentation
1. In the initial year of application of SFAS 116 and/or SFAS 117, is the nature of 
any restatement and its effect on the change in net assets for each period 
presented disclosed?
[SFAS 116, par. 30; SFAS 117, par. 31] ------
2. Does the statement of financial position report total assets, liabilities, and net 
assets as well as separate amounts for each of three classes of net assets and total 
net assets, with captions used to describe their meaning as explained in SFAS 
117?
[SFAS 117, pars. 10,13, and 100 (AC No5.131, fn. a)]
3. Are cash and other assets received with a donor-imposed restriction that limits 
their use to long-term purposes reported separately from assets that are 
unrestricted and available for current use?
[SFAS 117, par. 11 (AC No5.109)]
4. Does the provider give information about liquidity by one or more of the 
following presentations:
a. Sequencing assets according to their nearness of conversion to cash and 
sequencing liabilities according to the nearness of their maturity and resulting
use of cash? ____
b. Classifying assets and liabilities as current and noncurrent? ____
c. Disclosing in notes to financial statements relevant information about the 
liquidity or maturity of assets and liabilities, including restrictions on the use 
of particular assets?
[SFAS 117, par. 12 (AC No5.110)]
5. Does the providers give information about the nature and amounts of different 
types of permanent restrictions and temporary restrictions by reporting their 
amounts provided on the face of the statement of financial position or by 
including relevant details in the notes to the financial statements?
[SFAS 117, par. 14 (AC No5.112)]
6. Are limits on the use of unrestricted net assets (such as loan covenants and board- 
designated endowments) disclosed in the notes to or on the face of the financial 
statements?
[SFAS 117, par. 16 (AC No5.114)]
7. Are interfund receivables and payables clearly identified and arranged in the 
statement of financial position to eliminate their amounts when displaying total 
assets or liabilities?
[SFAS 117, par. 85, fn. 8 (AC No5.109, fn.4)]
D. Statement of Operations
1. Does the statement of operations report the amount of change in net assets for 
the period for the provider as a whole (using a descriptive term such as “change 
in net assets"), and does that amount articulate to the net assets reported in the 
statement of financial position?
[SFAS 117, par. 18 (AC No5.116)]
2. Does the statement of operations report the amount of change in permanently 
restricted net assets, temporarily restricted net assets, and unrestricted net assets 
for the period?
[SFAS 117, par. 19 (AC No5.117)]
3. Does the statement of operations report the following:
a. Revenues as increases in unrestricted net assets unless the use of the assets
received is limited by donor-imposed restrictions? ____
b. Expenses as decreases in unrestricted net assets? ____
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c. Events that simultaneously increase one class of net assets and decrease 
another (reclassifications), including expiration of donor-imposed restrictions, 
separately from revenues, expenses, gains, and losses?
[SFAS 117, pars. 19-20 (AC No5.117-118); SFAS 116, par. 17 (AC No5.146)]
4. Does the provider report gains and losses on investments or other assets (or 
liabilities) as increases or decreases in unrestricted net assets, unless their use is 
temporarily or permanently restricted by explicit donor stipulations or by law?
[SFAS 117, par. 22 (AC No5.119)]
5. Does the organization report gains and losses on endowments in the following 
manner:
a. As an increase or decrease in permanently restricted net assets if the 
governing board has determined that the relevant law requires the provider to 
retain permanently some portion of gains on investments?
[SFAS 117, pars. 22 and 129 (AC No5.119 and No.5.119 fn8)]
b. As an increase or decrease in unrestricted or temporarily restricted net assets, 
whichever is consistent with the reporting of the endowment's income, in the 
absence of such a law as noted in 5a.?
[SFAS 117, par. 129 (AC No5.119, fn. 8)]
6. If the provider reports an intermediate measure of operations (for example, excess 
or deficit of operating revenues over expenses), is this intermediate measure 
reported only in a financial statement that, at a minimum, reports the change in 
unrestricted net assets for the period?
[SFAS 117, par. 23 (AC No5.120)]
7. If the provider's use of the term operations is not apparent from the details 
provided on the face of the statement of operations, does a note to financial 
statements describe the nature of the reported measure of operations or the items 
excluded from operations?
[SFAS 117, par. 23 (AC No5.120)]
8. Does the statement of operations report gross amounts of revenues and expenses?
[SFAS 117, par. 24 (AC No5.121)]
9. If the provider elects to report investment revenues net of related expenses, does 
the provider disclose the amount of expenses, either on the face of the statement 
of operations or in the notes to financial statements?
[SFAS 117, par. 24 (AC No5.121)]
10. If the provider reports net gains and losses on its statement of operations, do 
these gains and losses result from peripheral or incidental transactions or from 
events largely beyond the control of the provider and its management?
[SFAS 117, par. 25 (AC No5.122)J
11. Does the provider give information about expenses reported by their functional 
classification (such as major classes of program services and supporting services) 
either in the statement of operations or in the notes to the financial statements?
[SFAS 117, par. 26 (AC No5.123)]
12. If comparative annual financial statements are presented for earlier periods, are 
those financial statements reclassified (or restated) to reflect retroactive
application of the provisions of SFAS 116 and SFAS 117? _____
[SFAS 116, par. 30; SFAS 117, par. 31]
13. In its statement of cash flows, does the provider include in cash flows from 
financing activities any amounts received with donor-imposed stipulations that
they must be used for long-term purposes? _____
[SFAS 117, par. 30(c) (AC C25.116)]
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Auditors’ Reports Checklist
.01 This checklist has been developed by the staff of the Technical Information Division of the AICPA as a 
nonauthoritative practice aid.
.02 Explanation of References:
SAS = AICPA Statement on Auditing Standards
AU = Reference to section number in AICPA Professional Standards (vol. 1)
SSARS = FASB Statements on Standards for Accounting and Review Services
AR = Reference to section number in AICPA Professional Standards (vol. 2)
.03 Checklist Questionnaire
Yes No N/A
1. Does the auditor's report include appropriate:
a. Addressee? -------- -------- --------
[SAS 58, par. 9 (AU 508.09)]
b. Date (or dual dates) of the report? -------- -------- --------
[SAS 1, sec. 530.05 (AU 530.05)]
c. A title that includes the word "independent"? _____ _____ _____
[SAS 58, par.8a (AU 508.08a)]
2. If the auditor is not independent, is the appropriate disclaimer expressed,
regardless of the extent of services provided? -------- -------- --------
[SAS 26, par. 10 (AU 504.10); SSARS 1, pars. 22 and 38 (AR 100.22 and 38)]
3. Does the reporting language conform with the auditor's standard report on:
a. Financial statements of a single year or period? _____ _____ _____
b. Comparative financial statements? -------- -------- --------
[SAS 58, par. 8 (AU 508.08)]
4. Does the report include appropriate language for the following situations:
a. Only one basic financial statement is presented and there are no scope
limitations? -------- -------- --------
[SAS 58, par. 47—48 (AU 508.47—.48)]
b. Audited and unaudited financial statements are presented in comparative
form? -------- -------- --------
[SAS 26, pars. 14—17 (AU 504.14—.17)]
5. Is an explanatory paragraph (or other explanatory language) added to the 
standard report if:
a. The financial statements are affected by uncertainties concerning future events, 
the outcome of which is not susceptible of reasonable estimation at the date
of the auditor's report? -------- -------- --------
[SAS 58, pars. 16—33 (AU 508.16—.33)]
Note: Consult the Topical Index to the AICPA Professional Standards under
b. There is substantial doubt about the entity's ability to continue as a going 
concern for a reasonable period of time and that conclusion is expressed 
through the use of the phrase "substantial doubt about its (the entity's)
ability to continue as a going concern"? -------- -------- --------
[SAS 64, par. 1 (AU 341.12—.13)]
39
Yes
c. There is a material change between periods in accounting principles or in the
method of their application? _____
[SAS 58, pars. 34—36 (AU 508.34—.36)]
d. In an updated report on comparative financial statements, the current opinion
on the prior period is different from the one previously expressed? _____
[SAS 58, pars. 77—78 and 81—82 (AU 508.77—.78 and .81—.82)]
e. The prior period financial statements are audited by a predecessor auditor
whose report is not presented? _____
[SAS 64, par. 2 (AU 508.83)]
f. The auditor's opinion is based in part on the report of another auditor? _____
[SAS 1, sec. 543 (AU 543); SAS 58, pars.12—13 (AU 508.12—.13)]
g. The financial statements contain a departure from a promulgated accounting 
principle when conformity with GAAP would result in a misleading
presentation? _____
SAS 58, pars. 14—15 (AU 508.14—.15)]
h. Other information in a document containing audited financial statements is 
materially inconsistent with information appearing in the financial
statements? _____
[SAS 8, par. 4 (AU 550.04)]
i. The auditor decides to emphasize a matter in the report? _____
[SAS 58, par. 37 (AU 508.37); Interpretation 38 of SAS 1, sec. 410 (AU 
9410.17); Interpretation 1 of SAS 57 (AU 9342.03)]
6. Is a qualified opinion or disclaimer of opinion expressed if scope limitations 
preclude application of one or more auditing procedures considered necessary in
the circumstances? _____
[SAS 58, pars. 40—45 (AU 508.40—.45); SAS 31, par. 22 (AU 326.23); SAS 19, 
par. 12 (AU 333.12)]
Note: Consult the Topical Index to the AICPA Professional Standards under 
"Scope of Audit—Limitations" for additional references to specific types of scope 
limitations that could result in either a qualified or disclaimer of opinion.
7. Is a qualified opinion or adverse opinion expressed if a lack of conformity with
GAAP (including inadequate disclosure) is present? _____
[SAS 58, pars. 49—66 (AU 508.49—.66); SAS 32, par. 3 (AU 431.03)]
Note: Consult the Topical Index to the AICPA Professional Standards under 
"Departures from Established Principles," "Adverse Opinions," and "Qualified 
Opinions" for additional references to specific types of GAAP departures that 
could result in either a qualified or adverse opinion.
8. Is a qualified or adverse opinion expressed if the entity specifically requests the 
auditor to report on prior-period financial statements that are incomplete (e.g.,
prior-period totals only)? _____
[SAS 58, fn. 27 (AU 508, fn. 27)]
9. If a qualified opinion, adverse opinion, or disclaimer of opinion is expressed, are 
all the substantive reasons for the opinion or disclaimer disclosed and is the
reporting language appropriately modified? _____
[SAS 58, pars. 39, 68—69 and 71 (AU 508.39, .68—.69, and .71)]
10. If the auditor is requested to audit Internal Revenue Form 990, "Return of
Organizations Exempt from Income Tax," is the appropriate report prepared? _____
[Interpretation 2 of SAS 62 (AU 9623.47—.54)]
11. If information accompanies the basic financial statements and auditor's report in 
an auditor-submitted document, does the report on the accompanying 
information:
a. State that the audit is performed for the purpose of forming an opinion on the
basic financial statements taken as a whole? _____
b. Specifically identify the accompanying information? --------
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Yes
c. State that the accompanying information is presented for purposes of
additional analysis and is not a required part of the basic financial statements? --------
d. State whether the accompanying information is subject to the auditing 
procedures applied in the audit of the basic financial statements and the
appropriate expression of opinion or disclaimer? --------
[SAS 29, pars. 6—11 (AU 551.06—.11)]
12. Is the reporting form and content of SAS 60, paragraphs 9—19, followed when
communicating internal control structure related matters noted in an audit?1 --------
[SAS 60, pars. 9—19 (AU 325.09—.19)]
13. Is the reporting form and content of SAS 72 followed for comfort letters 
submitted to underwriters and other requesting parties on tax-exempt bond
offerings? --------
[SAS 72 (AU 634)]
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Auditors’Reports on Audits Performed Under 
Government Auditing Standards and OMB 
Circular A-133 Checklist1
1 On March 8, 1990, The Office of Management and Budget issued Circular A-133, Audits of Institutions of Higher Education and Other 
Nonprofit Organizations, to implement a "single audit" requirement for not-for-profit institutions. Circular A-133 requires that the auditor 
perform the audit in accordance with Government Auditing Standards (the "Yellow Book") issued by the Comptroller General of the United 
States.
SAS No. 74, Compliance Auditing Considerations in Audits of Governmental Entities and Recipients of Governmental Financial Assistance, 
provides guidance on planning, performing, and reporting on the compliance aspects of audits in accordance with GAAS, GAO Standards, 
Circular A-133, and Circular A-128, which applies to State and Local Governmental entities.
On December 28, 1992, the AICPA issued SOP 92-9, Audits of Not-for-Profit Organizations Receiving Federal Awards, to provide guidance 
on the auditor's responsibilities when conducting an audit in accordance with Circular A-133. It incorporates the guidance in OMB's October 
1991 Compliance Supplement for Audits of Institutions of Higher Learning and Other Nonprofit Institutions, and the President's Council on 
Integrity and Efficiency Standards Subcommittee's Position Statement No. 6 (A-133 Questions and Answers).
2 See the checklist for auditor's reports on the basic financial statements.
.01 This checklist has been developed by the staff of the Technical Information Division of the AICPA as a 
nonauthoritative practice aid.
.02 This checklist has two parts: Part I is for reports on audits performed under Government Auditing 
Standards ("Yellow Book"). Part II contains the additional requirements for reports on audits performed in 
accordance with OMB Circular A-133. For audits performed under Circular A-133, both Parts I and II of this 
checklist must be completed.
.03 Explanation of References:
A-133 = Office of Management and Budget (OMB) Circular A-133
GAS = Government Auditing Standards ("Yellow Book," issued by GAO, 1994 Revision)
SAS = AICPA Statement on Auditing Standards
AU = Reference to section number in AICPA Professional Standards (vol. 1)
SOP 92-9 = AICPA Statement of Position, Audits of Not-for-Profit Organizations Receiving Federal 
Awards
.04 Checklist Questionnaire
Yes No N/A
Part I—Reports on Audits Performed in Accordance with Government
Auditing Standards (the "Yellow Book")
1. In an audit performed in accordance with the Yellow Book, are the following 
reports issued:
a. A report on the provider's basic financial statements? 2 -------- -------- --------
b. A report on internal control structure? -------- -------- --------
c. A report on compliance with laws and regulations that may have a direct and
material effect on the basic financial statements? -------- -------- --------
[SOP 92-9, par. 7.2]
43
Yes No N/A
2. Does each report listed in Step 1. above contain a statement that the audit was 
conducted in accordance with generally accepted auditing standards and the 
Yellow Book?3
3 SOP 92-9, paragraph 7.4, states that federal reviewers accept reports on the basic financial statements only that do not refer to Government 
Auditing Standards. However, state reviewers and others may insist on full compliance with the "Yellow Book" requirement. Practitioners are 
advised to determine the requirements of any non-federal reviewers before deleting the reference to Government Auditing Standards in 
reports on the basic financial statements.
4 Under the Yellow Book, a report on the internal control structure is required in all audits, even if no reportable conditions were noted.
5 If there are no immaterial instances of noncompliance, the auditor may so note in the report. [SOP 92-9, par. 7.24]
[GAS, Chap. 5, par. 11; SOP 92-9, par. 7.4] -------- -------
Report on Internal Control Structure 4
3. Does the report on internal control structure conform to the standard report
illustrated in Exhibit D-3 of Appendix D of SOP 92-9? _____ _____ _____
4. If material weaknesses were noted, are the condition, criteria, and effect of those 
material weaknesses disclosed in the report?
[GAS, Chap. 6, pars. .49-.52, fn. 7]
5. If the auditor determines that deficiencies in the internal control structure were 
not significant enough to be considered reportable conditions (referred to as 
"nonreportable conditions"), are those matters communicated separately to the 
provider in writing (or orally, with working paper documentation)?
[GAS, Chap. 5, par. 27 and Chap. 7, par. 29]
6. If a separate written communication describing nonreportable conditions is 
issued, does the report on internal controls refer to that separate communication?
[SOP 92-9, par. 7.12]
7. If no reportable conditions were noted during the audit, has the report or internal 
control structure been modified in accordance with note 3 to Exhibit D-3 of 
appendix D to SOP 92-9?
[SOP 92-9, par. 7.11]
Report on Compliance With Laws and Regulations
8. Does the report on compliance with laws and regulations conform to the standard
report illustrated in Exhibits D-4 to D-7 in Appendix D of SOP 92-9? _____ _____ _____
9. In rare circumstances in which the auditor decides not to test compliance with 
laws and regulations, does the report contain a statement that compliance with 
laws and regulations was not tested?
[SOP 92-9, Appendix D, Exhibit D-7]
10. Did the auditor consider the best estimate of total costs questioned for each major 
federal financial assistance program (likely questioned costs) in evaluating the 
effect of questioned costs on the opinion on compliance?
[SAS 74, par. 18]
11. If the auditing procedures disclose material instances of noncompliance, is the 
report on compliance appropriately modified?
[SAS 74, par. 19]
12. If the report contains material instances of noncompliance, is the effect of such 
misstatements on the auditor's report on the basic financial statements 
considered?
[SAS 74, par. 20]
13. Are immaterial instances of noncompliance reported in a separate
communication to the provider?5 _____ _____ _____
[SAS 74, par. 19; GAS, Chap. 7, par. 29]
14. If a separate letter describing immaterial instances of noncompliance is issued, 
does the compliance report refer to that letter?
[SOP 92-9, par. 7.16]
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15. If the auditor becomes aware of illegal acts or of possible illegal acts, are they
communicated to management? _____ _____ ____
[GAS, Chap. 5, par. 18]
16. If the auditor becomes aware of illegal acts and remains uncertain about whether 
they materially affect the financial statements, is the report on the financial 
statements qualified or a disclaimer of opinion issued?
[SOP 92-9, par. 7.18]
Other Matters
17. If performance audits are required by contractual obligations, are findings
presented in accordance with the guidance in the Yellow Book? _____ _____ ____
[GAS, Chap. 7, pars. 17, 21, 26 and 34]
18. If the auditor is unable to follow an applicable standard and is unable to 
withdraw from the engagement, did the auditor disclose in the scope section of 
the report on the financial statements the fact that an applicable standard is not 
followed, the reasons therefor, and the known effect of not following the
standard on the results of the audit? _____ _____ ____
[GAS, Chap. 3, pars. 27-29]
19. Does the auditor's report on the financial statements disclose the status of known 
but uncorrected significant or material findings and recommendations from prior
audits that could have an effect on the current audit objective? _____ _____ ____
[GAS, Chap. 4, par. 10; SOP 92-9, par. 7.41]
20. Did the auditor consider the impact on his or her report on the financial 
statements of the effects of noncompliance findings from other simultaneous 
audits that may result in claims for refunds?
[SOP 92-9, par. 7.43; SFAS 5 (AC C59)]
21. Do the reports on compliance and internal control structure carry the same date 
as the report on the basic financial statements?
[SOP 92-9, par. 7.27]
Part II—Reports on Audits Performed Under OMB Circular A-133
1. If the provider is subject to the requirements of Circular A-133, are the following 
additional reports issued:
a. A report on the supplementary schedule of federal awards?6 _____ _____ _____
b. A report on the internal control structure policies and procedures used to
6 Under Circular A-133, a recipient or subrecipient of an award is required to prepare a schedule of federal awards. A sample schedule and 
the auditor's report thereon are presented in the Financial Statements section of these checklists and Appendix E of SOP 92-9. [Attachment to 
Circular A-133, par. 15(c)(1); SOP 92-9, pars. 4.7 and 7.20]
7 If the provider has no nonmajor programs, or if the auditor has not selected any nonmajor program transactions, this report is not required. 
[SOP 92-9, par. 7.26]
8 A report on compliance with general requirements is required regardless of whether there are any major programs. [SOP 92-9, par. 7.25]
9 SOP 92-9, paragraph 7.4, states federal reviewers have accepted reports on the basic financial statements only that do not refer to 
Government Auditing Standards. However, state reviewers and others may insist on full compliance with the “Yellow Book" requirement.
administer federal awards? -------- -------- -------
c. A report on compliance with specific laws and regulations that may have a
direct and material effect on each major program? -------- -------- -------
d. A report on compliance with certain laws and regulations applicable to
nonmajor programs?7 -------- -------- -------
e. A report on compliance with general requirements?8 -------- -------- -------
[SOP 92-9, par. 7.19]
2. Does each auditor's report listed in Step 1. above contain a statement that the 
audit was conducted in accordance with GAAS; Government Auditing Standards 
issued by the Comptroller General of the United States; and Office of
Management and Budget (OMB) Circular A-133?9 -------- -------- -------
[SOP 92-9, Appendix D, Exhibits D-1, D-2, and D-8 through D-18]
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Report on Internal Control Structure Used in Administering Federal Awards
3. Does the report on the internal control structure used in administering federal 
awards conform to the standard report illustrated in Exhibit D-8 in Appendix D of
SOP 92-9? _____ _____ ____
4. If the auditor does not test controls because he or she determined that control 
policies and procedures are likely to be ineffective in preventing or detecting
noncompliance, is that matter disclosed as a "reportable condition"? _____ _____ ____
5. If the auditor limits his or her consideration of the internal control structure for 
any reason, are the circumstances disclosed in the report on the internal control
structure? _____ _____ _____
[SOP 92-9, par. 7.23]
Report on Compliance With Specific Requirements Related to Major Programs
6. For audits of major programs, does the report on compliance with specific 
requirements conform with the standard report illustrated in Exhibits D-9
through D-14 in Appendix D of SOP 92-9? _____ _____ _____
7. If the auditor is disclaiming an opinion due to a scope limitation:
a. Are the reasons indicated, in a separate paragraph, as to why the audit does
not comply with GAAS, the Yellow Book, or OMB Circular A-133? _____ _____ _____
b. Does the auditor state that the scope of the audit was not sufficient to warrant
the expression of an opinion? _____ _____ _____
c. Does the auditor disclose any reservations he or she has regarding compliance
with applicable laws and regulations? _____ _____ _____
[SOP 92-9, Appendix D, Exhibit D-13]
8. If the auditing procedures disclosed instances of noncompliance on major 
programs:
a. Does the resulting modification to the auditor's report on compliance consider 
factors that include:
1. The number and types of instances of noncompliance? _____ _____ _____
2. Determinability of questioned costs? _____ _____ _____
3. Materiality of questioned costs? _____ _____ _____
b. If, after considering those factors, the auditor concludes that the instances of 
noncompliance have a material effect on a federal program, is a qualified or
adverse opinion issued? _____ _____ _____
or
c. If, after considering those factors, the auditor is unable to determine if the 
instance of noncompliance could have a material effect on the program, does 
the report state that noncompliance occurred but the effect on the programs
presently cannot be determined? _____ _____ _____
(1) Is the effect of such uncertainties considered and, if necessary, is the
report on the financial statements modified? _____ _____ _____
[SOP 92-9, par. 7.24]
9. If the auditor is unable to examine appropriate evidence to support the comply/
noncomply decision, is the report appropriately modified? _____ _____ _____
[SOP 92-9, par. 7.24]
Report on Compliance With General Requirements
10. Does the report on compliance with general requirements conform to the 
standard report illustrated in Exhibits D-15 through D-17 in Appendix D of SOP 
92-9? _____ _____ _____
(Footnote Continued)
Practitioners are advised to determine the requirements of any nonfederal reviewers before deleting the reference to Government Auditing 
Standards in reports on the basic financial statements.
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Report on Compliance Related to Nonmajor Programs
11. For nonmajor programs, does the report on compliance conform to the standard
report illustrated in Exhibit D-18 in Appendix D of SOP 92-9? --------
General
12. Does each auditor's report on compliance with laws and regulations include for 
each federal award:
a. An identification of total amounts questioned as a result of noncompliance? --------
b. Any corrective action recommended by the auditor? --------
[SOP 92-9, pars. 7.30 and 7.32]
13. Are any immaterial findings included either (1) in a schedule of findings and
costs or (2) in a separate communication to management? --------
[SOP 92-9, par. 7.30]
14. If the audit is biennial, are both years within the period covered? --------
[SOP 92-9, par. 2.47]
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FSP Section 21,600 
Illustrative Financial Statements
.01 The following illustrative auditors' reports and financial statements demonstrate the practical applications 
of the reporting practices discussed in the AICPA Audit and Accounting Guide, Audits of Providers of Health Care 
Services (the Guide). The checklists and illustrative financial statements do not include all disclosures and 
presentation items promulgated. Pronouncements deemed remote for audits of health care providers are not 
included in this document. Specific types of health care organizations have been selected to illustrate a wide 
diversity of reporting practices; it is not intended that these illustrations represent either the only types of 
disclosure or the only statement formats that would be appropriate. Health care providers are urged to develop 
financial statement formats that are appropriate for their individual circumstances while being consistent with the 
accounting and reporting practices discussed in the Guide.
Note: The illustrative financial statements in this section do not conform to the requirements of FASB (SFAS) 
Statement No. 117, Financial Statements of Not-for-Profit Organizations. SFAS 117 is effective for annual 
financial statements issued for fiscal years beginning after December 15, 1994, except for organizations with less 
than $5 million in total assets and less than $1 million in annual expenses. For those organizations, the Statement 
is effective for fiscal years beginning after December 15, 1995.
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.02
The checklists and illustrative financial statements do not include all disclosures 
and presentation items promulated.
SAMPLE HOSPITAL
Balance Sheets
(Disaggregated "Layered" Reporting Approach)
December 31, 19X7 and 19X6
Assets
General Funds 
Current assets
Cash and cash equivalents..............
Assets whose use is limited— 
required for current liabilities
(notes 5, 7, and 8).......................
Patient accounts receivable, net of 
estimated uncollectibles of 
$2,500,000 in 19X7 and 
$2,400,000
in 19X6 (note 15)...........................
Estimated third-party payor
settlements—Medicare
(notes 3 and 15)...........................
Supplies, at lower of cost 
(first-in, first-out) or market___
Other current assets.........................
Due from donor-restricted funds ..
Total current assets..................
Assets whose use is limited (notes 5, 
7, and 8)
By board for capital improvements 
By agreements with third-party 
payors for funded depreciation . 
Under malpractice funding 
arrangement—held by trustee .. 
Under indenture agreement— 
held by trustee...............................
Total assets whose use is 
limited......................................
Less assets whose use is limited 
and that are required for current 
liabilities...........................................
Noncurrent assets whose use
is limited..................................
Property and equipment, net (notes 
6 and 7)
Other assets
Prepaid pension cost (note 12)___
Deferred financing costs..................
Investment in affiliated company
(note 4).............................................
Total other assets......................
19X7 19X6 Liabilities and Fund Balances 19X7 19X6
Current liabilities
$ 3,103,000 $ 4,525,000 Current installments of long-term
debt (note 7)....................................
Current portion of capital lease
$ 970,000 $ 1,200,000
970,000 1,300,000 obligations (note 7)...................... 500,000 550,000
Accounts payable............................. 2,217,000 2,085,000
Accrued expenses............................. 3,396,000 3,225,000
15,100,000 14,194,000
Estimated third-party payor 
settlements—Medicaid (note 2). 2,143,000 1,942,000
Deferred third-party
reimbursement ............................. 200,000 210,000
441,000 600,000 Advances from third-party payors 
Current portion of estimated
122,000 632,000
500,0001,163,000 938,000 malpractice costs (note 8)...........
Retainage and construction
600,000
321,000 403,000 accounts payable........................... 955,000 772,000
— 500,000
Due to donor-restricted funds___ 300,000 —
21,098,000 22,460,000
Total current liabilities........... 11,403,000 11,116,000
11,000,000 10,000,000
Deferred third-party
9,234,000 6,151,000 reimbursement ............................. 746,000 984,000
3,007,000 2,682,000 Estimated malpractice costs, net of 
current portion (note 8)................ 3,207,000 2,182,000
11,708,000 11,008,000
34,949,000 29,841,000 Long-term debt, excluding current
installments (note 7).................... 22,644,000 23,614,000
970,000 1,300,000 Capital lease obligations,
excluding current portion (note 
7)........................................................ 500,000 400,000
33,979,000 28,541,000 Fund balance...................................... 69,310,000 64,567,000
51,038,000 50,492,000
85,000 35,000
693,000 759,000
917,000 576,000 Commitments and contingent
1,695,000 1,370,000 liabilities (notes 3, 6, 8,12, and
$107,810,000 $102,863,000 13) ...................................................
$107,810,000 $102,863,000
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SAMPLE HOSPITAL
.02 Balance Sheets—continued
(Disaggregated "Layered" Reporting Approach)
December 31, 19X7 and 19X6
See accompanying notes to financial statements.
Assets 19X7 19X6 Liabilities and Fund Balances 19X7 19X6
Donor-Restricted Funds 
Specific-purpose funds
Cash.................................................... .$ 378,000 $ 378,000 Accounts payable........................ ...$ 205,000 $ 72,000
Investments, at cost that Deferred grant revenue............... 92,000 —
approximates market................ 728,000 455,000 Due to general funds.................... — 255,000
Grants receivable ........................... 613,000 535,000 Fund balance................................. 1,422,000 1,041,000
$ 1,719,000 $ 1,368,000 $ 1,719,000 $ 1,368,000
Plant replacement and expansion
Cash................................................... 24,000 321,000 Due to general funds.................... __ 345,000
Investments, at cost that Fund balance................................. 558,000 521,000
approximates market................
Pledges receivable, net of
estimated uncollectibles of
252,000 165,000
$60,000 in 19X7 and $120,000 
in 19X6........................................... 132,000 380,000
Due from general funds................ 150,000 —
$ 558,000 $ 866,000 $ 558,000 $ 866,000
Endowment funds
Cash....................................................
Investments, net of $175,000
1,253,000 653,000 Fund balance................................. 5,259,000 6,073,000
valuation allowance in 19X7, 
market value $3,798,000 in 
19X7 and $5,013,000 in 19X6 
(note 9)........................................... 3,856,000 5,320,000
Due from general funds................ 150,000 100,000
$ 5,259,000 $ 6,073,000 $ 5,259,000 $ 6,073,000
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SAMPLE HOSPITAL
.03 Balance Sheets
(Aggregated Approach)
December 31, 19X7 and 19X6
Assets 19X7 19X6 Liabilities and Fund Balances 19X7 19X6
Current assets Current liabilities
Current installments of long-term
$ 1,200,000Cash and cash equivalents.............
Assets whose use is limited—re­
quired for current liabilities (notes 
5, 7 and 8)...................................
$ 2,803,000 $ 5,025,000 debt (note 7)...............................
Current portion of capital lease obli­
gations (note 7) ..........................
Accounts payable ..........................
Accrued expenses..........................
Estimated third-party payor settle­
ments—Medicaid (note 2)...........
Deferred third-party reimbursement 
Advances from third-party payors.. 
Current portion of 
estimated malpractice 
costs (note 8) .............................
Retainage and construction ac­
counts payable ............................
Advances and deferred revenue....
Total current liabilities...............
Deferred third-party reimbursement.. 
Estimated malpractice costs, net of 
current portion (note 8)..................
Long-term debt, excluding current in­
stallments (note 7)..........................
Capital lease obligations, excluding
current installments (note 7)...........
Total liabilities........................
Net assets
Unrestricted...................................
Temporarily restricted by donors/ 
grantors.......................................
Permanently restricted by donors .. 
Total net assets........................
Commitments and contingent lia­
bilities (notes 3, 6, 8, 12 and 13)
$ 970,000
1,267,000 1,372,000 500,000 550,000
Patient accounts receivable, net of
estimated uncollectibles of
$2,500,000 in 19X7 and 
$2,400,000 in 19X6 (note 15) .... 15,100,000 14,194,000 2,422,000
3,396,000
2,157,000
3,225,000
Estimated third-party
payor settlements
—Medicare (notes
3 and 15)...................................
Supplies, at lower of
cost (first-in,
first-out) or market....................
Other current assets...................... .
Total current assets....................
Assets whose use is limited
or restricted (notes 5,
7, 8 and 9)
By board for capital improvements .
By agreements with third-party
payors for funded depreciation .. 
Under malpractice funding arrange­
ment—held by trustee.................
Under indenture agreement—held 
by trustee...................................
By donors or grantors for specific 
purposes.....................................
By donors for permanent endow­
ment funds .................................
Total assets whose use is limited or 
restricted.....................................
Less assets whose use is limited and 
that are required for current liabili­
ties ..................................................
Noncurrent assets whose use is lim­
ited or restricted..........................
Property and equipment, net (notes 5 
Other assets
Prepaid pension cost (note 12).......
Deferred financing costs.................
Investment in affiliated company
(note 4).......................................
Total other assets........................
2,143,000 1,942,000
441,000 600,000 200,000 210,000
122,000 632,000
1,163,000 938,000 600,000 500,000
955,000 772,000
321,000 403,000 92,000
21,095,000 22,532,000 11,400,000 11,188,000
11,000,000 10,000,000 746,000 984,000
9,234,000 6,151,000 3,207,000 2,182,000
3,007,000 2,682,000 22,644,000 23,614,000
11,708,000 11,008,000
2,277,000 1,634,000
5,259,000 6,073,000 500,000 400,000
38,497,000 38,368,000
42,485,000 37,548,000
69,310,000 64,567,000
1,372,0001,267,000 1,980,000 1,562,000
41,218,000 36,176,000 5,259,000 6,073,000
76,549,000 72,202,000
51,038,000 50,492,000
85,000 35,000
693,000 759,000
917,000 576,000
1,695,000 1,370,000
$115,046,000 $110,570,000 $115,046,000 $110,570,000
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SAMPLE HOSPITAL
.04 Statements of Revenue and Expenses of General Funds 
Years Ended December 31, 19X7 and 19X6
Net patient service revenue (notes 3,  7 and 15)....................................................................
Other revenue..............................................................................................................................
Total revenue ..................................................................................................................
Expenses (notes 7, 8, 12, and 13)
Professional care of patients..................................................................................................
Dietary services .......................................................................................................................
General services.......................................................................................................................
Administrative services .........................................................................................................
Employee health and welfare................................................................................................
Medical malpractice costs.......................................................................................................
Depreciation and amortization of property and equipment..........................................
Interest .......................................................................................................................................
Provision for bad debts...........................................................................................................
Total expenses..................................................................................................................
Income from operations................................................................................................
Nonoperating gains (losses)
Unrestricted gifts and bequests (note 10)...........................................................................
Loss on investment in affiliated company (note 4) ........................................................
Income on investments of endowment funds.................................................................
Income on investments whose use is limited
By board for capital improvements..................................................................................
By agreements with third-party payors for funded depreciation............................
Under indenture agreement.............................................................................................
Other investment income.......................................................................................................
Nonoperating gains, net................................................................................................
Revenue and gains in excess of expenses and losses..........................................................
See accompanying notes to financial statements.
19X7 19X6
$92,656,000
6,010,000
$88,942,000
5,380,000
98,666,000 94,322,000
53,016,000
4,407,000
10,888,000
11,075,000
10,000,000
1,125,000
4,782,000
1,752,000
1,010,000
48,342,000
4,087,000
9,973,000
10,145,000
9,335,000
200,000
4,280,000
1,825,000
1,103,000
98,055,000 89,290,000
611,000 5,032,000
822,000
(37,000)
750,000
926,000
(16,000)
650,000
1,120,000
850,000
100,000
284,000
1,050,000
675,000
90,000
226,000
3,889,000 3,601,000
$ 4,500,000 $ 8,633,000
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SAMPLE HOSPITAL
.05 Statements of Changes in Fund Balances
Years Ended December 31, 19X7 and 19X6
19X7 19X6
See accompanying notes to financial statements.
Balances at beginning of year..........
Additions
Revenue and gains in excess of
. $64,567,000 $1,041,000 $ 521,000 $6,073,000 $56,679,000 $ 933,000 $ 501,000 $5,973,000
expenses and losses...................
Gifts, grants, and bequests
. 4,500,000 — — — 8,633,000 — — —
(notes 10 and 11)....................... — 869,000 220,000 — — 558,000 290,000 —
Investment income.......................
Net realized gain on sale
. — 62,000 20,000 — — 50,000 15,000 —
of investments...........................
Transfer to finance property
. — — 100,000 — — — 20,000 100,000
and equipment additions.......... 243,000 — (243,000) — 255,000 — (255,000) —
Deductions
4,743,000 931,000 97,000 — 8,888,000 608,000 70,000 100,000
Provision for uncollectible pledges 
Capital contribution to Sample
. — — 60,000 — — — 50,000 —
Health System (note 11)............
Net realized loss on sale
1,000,000 — — —
of investments...........................
Unrealized loss on marketable
. — — — 639,000 — — — —
equity securities (note 9).......... — — — 175,000 — — — —
Transfer to other revenue............ — 550,000 — — — 500,000 — —
— 550,000 60,000 814,000 1,000,000 500,000 50,000 —
Balances at end of year..................... . $69,310,000 $1,422,000 $ 558,000 $5,259,000 $64,567,000 $1,041,000 $ 521,000 $6,073,000
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General 
Funds
Donor-Restricted Funds
Specific- 
Purpose 
Funds
Plant 
Replacement 
and Expan­
sion Funds
Endowment 
Funds
General 
Funds
Specific- 
Purpose 
Funds
Donor-Restricted Funds
Plant 
Replacement 
and Expan­
sion Funds
Endowment 
Funds
SAMPLE HOSPITAL
.06 Statements of Cash Flows of General Funds (Direct Method) *
Years Ended December 31, 19X7 and 19X6
19X7 19X6
Cash flows from operating activities and gains and losses
Cash received from patients and third-party payors........................................$ 90,342,000 $ 85,619,000
Cash paid to employees and suppliers................................................................ (89,214,000) (81,510,000)
Other receipts from operations...............................................................  6,042,000 5,563,000
Receipts from unrestricted gifts and bequests................................................... 1,122,000 905,000
Interest and dividends received............................................................................. 2,510,000 2,330,000
Interest paid (net of amount capitalized)........................................................... (1,780,000) (1,856,000)
Net cash provided by operating activities and gains and losses................ 9,022,000 11,051,000
Cash flows from investing activities
Purchase of property and equipment.................................................................. (4,728,000) (5,012,000)
Transfer from donor-restricted fund for purchase of property and
equipment.............................................................................................................. 243,000 255,000
Investment in affiliated company......................................................................... (394,000) (425,000)
Transfer to Sample Health System...................................................................... — (1,000,000)
Cash invested in assets whose use is limited..................................................... (4,798,000) (855,000)
Net cash used by investing activities .............................................................. (9,677,000) (7,037,000)
Cash flows from financing activities
Increase in retainage and construction accounts payable............................... 183,000 175,000
Repayment of long-term debt............................................................................... (1,200,000) (1,630,000)
Payments from donor-restricted funds related to temporary loans.............  500,000 —
Payments on capital lease obligations ................................................................ (550,000) (600,000)
Temporary loans from (to) donor-restricted funds.......................................... 300,000 (193,000)
Net cash used by financing activities.............................................................. (767,000) (2,248,000)
Net increase (decrease) in cash and cash equivalents.......................................... (1,422,000) 1,766,000
Cash and cash equivalents at beginning of year................................................... 4,525,000 2,759,000
Cash and cash equivalents at end of year................................................................$ 3,103,000 $ 4,525,000
See accompanying notes to financial statements.
* The direct and indirect methods of reporting cash flows by hospitals are presented for illustrative purposes. The indirect method is
presented on page 21,609.
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SAMPLE HOSPITAL
.06 Statements of Cash Flows of General Funds (Direct Method) *—continued
Years Ended December 31, 19X7 and 19X6
Reconciliation of Revenue and Gains in Excess of Expenses and Losses to Net 
Cash Provided by Operating Activities and Gains and Losses
Revenue and gains in excess of expenses and losses.......................................
Adjustments to reconcile revenue and gains in excess of expenses and
losses to net cash provided by operating activities and gains and losses
Depreciation and amortization of property and equipment..................
Provision for bad debts...................................................................................
Amortization of deferred financing costs...................................................
Loss on investment in affiliated company................................................
Noncash gifts and bequests...........................................................................
Decrease in amounts due to third-party payors.......................................
Increase in liability for estimated malpractice costs.................................
Increase in patient accounts receivable.......................................................
Increase in supplies and other current assets............................................
Increase in accounts payable and accrued expenses...............................
Increase in interest earned but not received on assets whose use is
limited............................................................................................................
Net cash provided by operating activities and gains and losses___ $ 9,022,000 $ 11,051,000
19X7 19X7
4,500,000 $ 8,633,000
4,782,000 4,280,000
1,010,000 1,103,000
66,000 45,000
53,000 —
— (175,000)
(398,000) (77,000)
1,125,000 200,000
(1,916,000) (3,141,000)
(193,000) (118,000)
303,000 301,000
(310,000) —
Supplemental Disclosures of Cash Flow Information
Sample Hospital entered into capital lease obligations of $600,000 for new equipment in 19X7. 
See accompanying notes to financial statements.
* The direct and indirect methods of reporting cash flows by hospitals are presented for illustrative purposes. The indirect method is
presented on page 21,609.
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SAMPLE HOSPITAL
.07 Statements of Cash Flows of General Funds (Indirect Method) *
19X7 19X6
Years Ended December 31,19X7 and 19X6
Cash flows from operating activities and gains and losses
Revenue and gains in excess of expenses and losses........................................
Adjustments to reconcile revenue and gains in excess of expenses and
losses to net cash provided by operating activities and gains and losses
Depreciation and amortization of property and equipment..................
Provision for bad debts....................................................................................
Amortization of deferred financing costs...................................................
Loss on investment in affiliated company................................................
Noncash gifts and bequests...........................................................................
Decrease in net amounts due to third-party payors.................................
Increase in liability for estimated malpractice costs.................................
Increase in patient accounts receivable.......................................................
Increase in supplies and other current assets............................................
Increase in accounts payable and accrued expenses...............................
Increase in interest earned but not received on assets whose use is 
limited.....................................................................................................................
Net cash provided by operating activities and gains and losses...........
Cash flows from investing activities
Purchase of property and equipment..................................................................
Transfer from donor-restricted fund for purchase of property and
equipment..............................................................................................................
Investment in affiliated company.........................................................................
Transfer to Sample Health System......................................................................
Cash invested in assets whose use is limited.....................................................
Net cash used by investing activities ..............................................................
Cash flows from financing activities
Increase in retainage and construction accounts payable...............................
Repayment of long-term debt...............................................................................
Payments from donor-restricted funds related to temporary loans.............
Payments on capital lease obligation..................................................................
Temporary loans from (to) donor-restricted funds..........................................
Net cash used by financing activities..............................................................
Net increase (decrease) in cash and cash equivalents..........................................
Cash and cash equivalents at beginning of year...................................................
Cash and cash equivalents at end of year................................................................
$ 4,500,000 $ 8,633,000
4,782,000 4,280,000
1,010,000 1,103,000
66,000 45,000
53,000 —
— (175,000)
(398,000) (77,000)
1,125,000 200,000
(1,916,000) (3,141,000)
(193,000) (118,000)
303,000 301,000
(310,000) —
9,022,000 11,051,000
(4,728,000) (5,012,000)
243,000 255,000
(394,000) (425,000)
(1,000,000)
(4,798,000) (855,000)
(9,677,000) (7,037,000)
183,000 175,000
(1,200,000) (1,630,000)
500,000 —
(550,000) (600,000)
300,000 (193,000)
(767,000) (2,248,000)
(1,422,000) 1,766,000
4,525,000 2,759,000
$ 3,103,000 $ 4,525,000
Supplemental Disclosures of Cash Flow Information
Sample Hospital entered into capital lease obligations of $600,000 for new equipment in 19X7.
Cash paid for interest (net of amount capitalized) in 19X7 and 19X6 was $1,780,000 and $1,856,000, 
respectively.
See accompanying notes to financial statements.
* The direct and indirect methods of reporting cash flows by hospitals are presented for illustrative purposes. The direct method is presented
on pages 21,607 and 21,608.
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SAMPLE HOSPITAL
.08 Notes to Financial Statements
December 31, 19X7 and 19X6
1. Summary of Significant Accounting Policies 
Organization
Sample Hospital (Hospital) is a not-for-profit acute care hospital. Effective June 30, 19X6, under a plan of 
reorganization, Sample Health System was formed as the parent holding company of the Hospital. In its 
capacity as sole member of the Hospital, Sample Health System has the right to appoint Hospital trustees, 
approve major Hospital expenditures, and approve long-term Hospital borrowings.
Charity care
The Hospital provides care to patients who meet certain criteria under its charity care policy without charge or 
at amounts less than its established rates. Because the Hospital does not pursue collection of amounts 
determined to qualify as charity care, they are not reported as revenue.
Income taxes
The Hospital is a not-for-profit corporation as described in Section 501(c)(3) of the Internal Revenue Code 
and is exempt from federal income taxes on related income pursuant to Section 501(a) of the Code.
Net patient service revenue
Net patient service revenue is reported at the estimated net realizable amounts from patients, third-party 
payors, and others for services rendered, including estimated retroactive adjustments under reimbursement 
agreements with third-party payors. Retroactive adjustments are accrued on an estimated basis in the period 
the related services are rendered and adjusted in future periods as final settlements are determined. 
Investments and investment income
Donated investments are reported at fair value at the date of receipt, which is then treated as cost. Marketable 
equity securities included in investment portfolios are carried at the lower of aggregate cost (determined on an 
average-cost basis) or market at the balance sheet date. Other marketable securities are stated at cost, adjusted 
for impairments in value that are deemed to be other than temporary. Sample Hospital's investment in 
Affiliated Company is reported on the equity method of accounting that approximates Sample Hospital's 
equity in the underlying net assets of Affiliated Company.
Investment income on proceeds of borrowings that are held by a trustee, to the extent not capitalized, and 
investment income on assets deposited in the malpractice trust are reported as other revenue. Investment 
income from all other general fund investments and investment income of endowment funds are reported as 
nonoperating gains. Investment income and gains (losses) on investments of donor-restricted funds are added 
to (deducted from) the appropriate restricted fund balance.
Pledges
Pledges, less an allowance for uncollectible amounts, are recorded as receivables in the year made. Un­
restricted pledges are reported in the statement of revenue and expenses of general funds; restricted pledges 
are reported as additions to the appropriate restricted fund balance.
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Statement of revenue and expenses of general funds
For purposes of display, transactions deemed by management to be ongoing, major, or central to the 
provision of health care services are reported as revenues and expenses. Peripheral or incidental transactions 
are reported as gains and losses.
Costs of borrowing
Interest cost incurred on borrowed funds during the period of construction of capital assets is capitalized as a 
component of the cost of acquiring those assets.
Deferred financing costs are amortized over the period the obligation is outstanding using the interest 
method.
Amortization of deferred financing costs is capitalized during the period of construction of capital assets. 
Donor-restricted funds
Donor-restricted funds are used to differentiate resources, the use of which is restricted by donors or grantors, 
from resources of general funds on which donors or grantors place no restriction or that arise as a result of the 
operations of the Hospital for its stated purposes. Restricted gifts and other restricted resources are recorded 
as additions to the appropriate restricted fund.
Resources restricted by donors for plant replacement and expansion are added to the general fund balance to 
the extent expended within the period.
Resources restricted by donors or grantors for specific operating purposes are reported in other operating 
revenue to the extent used within the period.
Assets whose use is limited
Assets whose use is limited include assets set aside by the Board of Trustees for future capital improvements, 
over which the Board retains control and may at its discretion subsequently use for other purposes; assets set 
aside in accordance with agreements with third-party payors; and assets held by trustees under indenture 
agreements and self-insurance trust arrangements.
Property and equipment
Property and equipment acquisitions are recorded at cost. Property and equipment donated for hospital 
operations are recorded as additions to the donor-restricted plant replacement and expansion funds at fair 
value at the date of receipt and as transfers to the general fund balance when the assets are placed in service.
Depreciation is provided over the estimated useful life of each class of depreciable asset and is computed on 
the straight-line method. Equipment under capital leases is amortized on the straight-line method over the 
shorter period of the lease term or the estimated useful life of the equipment. Such amortization is included in 
depreciation and amortization in the financial statements.
An accelerated method for depreciating certain operating equipment acquired before 1970 has been elected 
for third-party reimbursement purposes. Third-party reimbursement is deferred to the extent of the effect of 
the difference between accelerated depreciation used for reimbursement reporting and straight-line deprecia­
tion used for financial reporting.
Cash and cash equivalents
Cash and cash equivalents include investments in highly liquid debt instruments with a maturity of three 
months or less, excluding amounts whose use is limited by board designation or other arrangements under 
trust agreements or with third-party payors.
59
Estimated malpractice costs
The provision for estimated self-insured medical malpractice claims includes estimates of the ultimate costs 
for both reported claims and claims incurred but not reported.
2. Charity Care
The Hospital maintains records to identify and monitor the level of charity care it provides. These records 
include the amount of charges foregone for services and supplies furnished under its charity care policy, the 
estimated cost of those services and supplies, and equivalent service statistics. The following information 
measures the level of charity care provided during the years ended December 31, 19X7 and 19X6.
19X7 19X6
Charges foregone, based on established rates ......................................................... $6,000,000 $5,700,000
Estimated costs and expenses incurred to provide charity care ........................... 5,600,000 5,000,000
Equivalent percentage of charity care patients to all patients served ................ 5.7% 5.6%
3. Net Patient Service Revenue
The Hospital has agreements with third-party payors that provide for payments to the Hospital at amounts 
different from its established rates. A summary of the payment arrangements with major third-party payors 
follows.
• Medicare. Inpatient acute care services rendered to Medicare program beneficiaries are paid at prospec­
tively determined rates per discharge. These rates vary according to a patient classification system that is 
based on clinical, diagnostic, and other factors. Inpatient nonacute services, certain outpatient services, 
and defined capital and medical education costs related to Medicare beneficiaries are paid based upon a 
cost reimbursement methodology. The Hospital is reimbursed for cost reimbursable items at a tentative 
rate with final settlement determined after submission of annual cost reports by the Hospital and audits 
thereof by the Medicare fiscal intermediary. The Hospital's classification of patients under the Medicare 
program and the appropriateness of their admission are subject to an independent review by a peer 
review organization under contract with the Hospital. The Hospital's Medicare cost reports have been 
audited by the Medicare fiscal intermediary through December 31, 19X6.
• Medicaid. Inpatient and outpatient services rendered to Medicaid program beneficiaries are reimbursed 
under a cost reimbursement methodology. The Hospital is reimbursed at a tentative rate with final 
settlement determined after submission of annual cost reports by the Hospital and audits thereof by the 
Medicaid fiscal intermediary. The Hospital's Medicaid cost reports have been audited by the Medicaid 
fiscal intermediary through December 31, 19X6.
• Blue Cross. Inpatient services rendered to Blue Cross subscribers are reimbursed at prospectively 
determined rates per day of hospitalization. The prospectively determined per diem rates are not subject 
to retroactive adjustment.
The Hospital has also entered into payment agreements with certain commercial insurance carriers, health 
maintenance organizations, and preferred provider organizations. The basis for payment to the Hospital 
under these agreements includes prospectively determined rates per discharge, discounts from established 
charges, and prospectively determined daily rates.
4. Investment in Affiliated Company
In 19X2, the Hospital entered into an agreement with two unrelated hospitals to establish and operate an 
ambulatory care center, Affiliated Company (Center). In accordance with this agreement, each hospital 
invested $970,000 for a 33⅓ percent equity interest in the common stock of the Center. The investment was 
made in installments during the years 19X5 through 19X7, and in May 19X7 the Center began operations. The 
investment is recorded on the equity method.
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Summarized financial information from the unaudited financial statements of the Center follows.
Current assets .........
Noncurrent assets .. 
Current liabilities ... 
Noncurrent liabilities 
Shareholders' equity
December 31, 19X7 December 31, 19X6
.. $1,779,000 
.. 4,052,000 
.. 1,566,000 
.. 1,514,000 
.. 2,751,000
Year  
$1,835,000
4,007,000
1,325,000
2,789,000
1,728,000
Ended
December 31, 19X7 December 31, 19X6
Revenue ................................................................................................................ $3,220,000 $2,899,000
Net loss.................................................................................................................. (111,000) (48,000)
5. Assets Whose Use Is Limited
Assets whose use is limited that are required for obligations classified as current liabilities are reported in 
current assets. The composition of assets whose use is limited at December 31, 19X7 and 19X6, is set forth in 
the following table. Investments are stated at cost that approximates market.
19X7 19X6
By board for capital improvements 
Cash and short-term investments $11,000,000 $10,000,000
By agreements with third-party payors for funded depreciation
Cash and short-term investments ....................................................................
U.S. Treasury obligations....................................................................................
Interest receivable.................................................................................................
$ 8,503,000 
316,000 
415,000
$ 5,712,000 
316,000 
123,000
$ 9,234,000 $ 6,151,000
Under malpractice funding arrangement—held by trustee
Cash and short-term investments ....................................................................
U.S. Treasury obligations....................................................................................
$ 1,058,000 $ 857,000
1,949,000 1,825,000
$ 3,007,000 $ 2,682,000
Under indenture agreement—held by trustee
Cash and short-term investments ....................................................................
U.S. Treasury obligations....................................................................................
Interest receivable.................................................................................................
$ 592,000 $ 1,260,000
11,024,000 9,674,000
92,000 74,000
$11,708,000 $11,008,000
6. Property and Equipment
A summary of property and equipment at December 31, 19X7 and 19X6, follows.
19X7 19X6
Land.............................................................................................................................
Land improvements .................................................................................................
Buildings and improvements.................................................................................
Equipment..................................................................................................................
Equipment under capital leases.............................................................................
Less accumulated depreciation and amortization ............................................
Construction in progress ........................................................................................
Property and equipment, net.............................................................................
$ 3,000,000 
472,000 
46,852,000 
29,190,000 
2,851,000
82,365,000
34,928,000
47,437,000
3,601,000
$51,038,000
$ 3,000,000 
472,000 
46,636,000 
26,260,000 
2,752,000
79,120,000
30,661,000
48,459,000
2,033,000
$50,492,000
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Construction contracts of approximately $7,885,000 exist for the remodeling of Hospital facilities. At Decem­
ber 31, 19X7, the remaining commitment on these contracts approximated $4,625,000.
7. Long-Term Debt and Capital Leases
A summary of long-term debt and capital leases at December 31, 19X7 and 19X6, follows,
19X7
9.25% Revenue Notes, due November 1, 19XX, collateralized by a pledge 
of the Hospital's gross receipts .........................................................................$21,479,000
9.25% mortgage loan, due January 19XX, collateralized by a mortgage on 
property and equipment with a depreciated cost of $1,800,000 at 
December 31, 19X7.............................................................................................. 2,010,000
9.75% note payable, due March 19XX, unsecured .......................................... 125,000
Total long-term debt........................................................................................ 23,614,000
Less current installments of long-term debt....................................................... 970,000
Long-term debt excluding current installments ........................................$22,644,000
Capital lease obligations, at varying rates of imputed interest from 9.8% to 
12.3%, on leased equipment with an amortized cost of $1,500,000 at 
December 31, 19X7 ............................................................................................... 1,000,000
Less current portion of capital lease obligations .............................................. 500,000
Capital lease obligations, excluding current portion ........................................$ 500,000
19X6
$22,016,000
2,127,000
671,000
24,814,000
1,200,000
$23,614,000
950,000
550,000
$ 400,000
Under the terms of the Revenue Note Indenture, the Hospital is required to maintain certain deposits with a 
trustee. Such deposits are included with assets whose use is limited in the financial statements. The Revenue 
Note Indenture also places limits on the incurrence of additional borrowings and requires that the Hospital 
satisfy certain measures of financial performance as long as the notes are outstanding.
Scheduled principal repayments on long-term debt and payments on capital lease obligations for the next five 
years are as follows:
Long-Term
Debt
19X8
19X9
19Y0
19Y1
19Y2
$ 970,000 
912,000 
983,000 
1,060,000 
1,143,000
$5,068,000
Obligations Under
Capital Leases
$ 500,000 
260,000 
260,000
95,000
Less amount representing interest on obligations under capital 
leases .......................................................................................................
1,115,000
115,000
$1,000,000
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A summary of interest cost and investment income on borrowed funds held by the trustee under the Revenue 
Note Indenture during 19X7 and 19X6 follows.
19X7 19X6
Interest cost
Capitalized .......................................................................................................
Charged to operations ....................................................................................
Investment income
Capitalized .......................................................................................................
Credited to other revenue .............................................................................
$ 740,000 
1,752,000
$2,492,000
505,000
330,000
$ 835,000
$ 740,000 
1,825,000
$2,565,000
663,000
386,000
$1,049,000
8. Medical Malpractice Claims
The Hospital is uninsured with respect to medical malpractice risks. Losses from asserted claims and from 
unasserted claims identified under the Hospital's incident reporting system are accrued based on estimates 
that incorporate the Hospital's past experience, as well as other considerations including the nature of each 
claim or incident and relevant trend factors. Accrued malpractice losses have been discounted at rates ranging 
from 7 percent to 9 percent. No accrual for possible losses attributable to incidents that may have occurred but 
that have not been identified under the incident reporting system has been made because the amount is not 
reasonably estimable.
The Hospital has established an irrevocable trust fund for the payment of medical malpractice claim 
settlements. Professional insurance consultants have been retained to assist the Hospital with determining 
amounts to be deposited in the trust fund.
9. Endowment Funds—Investments
Donor-restricted endowment fund investment portfolios include marketable equity securities that are carried 
at the lower of cost or market. Marketable equity securities of endowment funds at December 31, 19X7 and 
19X6, are summarized as follows:
Cost
Quoted Market 
Value
19X7
19X6
$1,476,000
1,620,000
$1,301,000
1,832,000
Gross Unrealized 
Gains
$ 8,000 
228,000
Gross Unrealized 
Losses
$183,000
16,000
Realized gains on marketable equity securities of endowment funds amounted to $10,000 in 19X7 and 
$50,000 in 19X6.
10. Assets Held in Trust
The Hospital is an income beneficiary of the Thomas A. Smith Trust. Because the assets of the trust are not 
controlled by the Hospital, they are not included in the Hospital's financial statements. At December 31, 
19X7, the market value of the assets totaled approximately $2,652,000. Distributions of income are made at 
the discretion of the trustees. Income distributed to the Hospital by the trust is restricted for construction or 
equipment additions and amounted to $150,000 in 19X7 and $140,000 in 19X6.
11. Related Party Transactions
Because of the existence of common trustees and other factors, the Hospital and Sample Health Foundation 
(Foundation) are related parties. The Foundation is authorized by the Hospital to solicit contributions on its 
behalf. In its general appeal for contributions to support the community's providers of health care services,
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the Foundation also solicits contributions for certain other health care institutions. In the absence of donor 
restrictions, the Foundation has discretionary control over the amounts, timing, and use of its distributions.
Contributions made by the Foundation to the Hospital during the years ended December 31, 19X7 and 19X6, 
are reported in the Hospital's financial statements as follows:
Unrestricted gifts and bequests ...........................................................................
Restricted contributions for—
Specific purposes.................................................................................................
Plant replacement and expansion ..................................................................
19X7 19X6
$375,000 $525,000
300,000 200,000
70,000 85,000
In addition, the Hospital made a capital contribution of $1,000,000 to Sample Health System during 19X6.
12. Pension Plan
The Hospital has a defined benefit pension plan covering substantially all of its employees. The plan benefits 
are based on years of service and employee compensation during the last five years of covered employment. 
The Hospital makes annual contributions to the plan equal to the amounts of net periodic pension cost. 
Contributions are intended to provide not only for benefits attributed to service to date but also for those 
expected to be earned in the future.
The actuarially computed net periodic pension cost for 19X7 and 19X6 included the following components:
19X7 19X6
Service cost-benefits earned during the period ............................................
Interest cost on projected benefit obligation .................................................
Actual return on plan assets .............................................................................
Net amortization and deferral...........................................................................
$ 905,000
700,000
(950,000)
70,000
$ 770,000 
650,000
(800,000)
80,000
Net periodic pension cost $ 725,000 $ 700,000
Assumptions used in the accounting for net periodic pension cost were as follows:
Discount rates ..................................................................................................................
Rates of increase in compensation levels ..................................................................
Expected long-term rate of return on assets ..............................................................
As of December 31
19X7 19X6
7.0% 7.0%
6.0 6.0
8.0 8.0
The following table sets forth the plan's funded status and amounts recognized in the Hospital's financial 
statements at December 31, 19X7 and 19X6.
19X7
Actuarial present value of benefit obligations
Vested benefit obligation ....................................................................................$ 8,020,000
Nonvested benefit obligation............................................................................. 1,900,000
Accumulated benefit obligation.................................................................... 9,920,000
Effect of projected future compensation levels.......................................... 1,000,000
Projected benefit obligation ........................................................................... 10,920,000
Plan assets at fair value (primarily listed stocks and U.S. bonds).................... 11,050,000
Plan assets in excess of projected benefit obligation ............................... 130,000
Unrecognized net gain from past experience different from that assumed . (30,000)
Prior service cost not yet recognized in net periodic pension cost................ 50,000
Unrecognized net asset at January 1, 19X6, being recognized
over 15 years .......................................................................................................... (65,000)
Prepaid pension cost, included in other assets in the balance sheet ........... $ 85,000
19X6
$ 6,800,000 
1,930,000
8,730,000
980,000
9,710,000
9,800,000
90,000
(40,000)
55,000
(70,000) 
$ 35,000
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13. Commitments
Leases that do not meet the criteria for capitalization are classified as operating leases with related rentals 
charged to operations as incurred.
The following is a schedule by year of future minimum lease payments under operating leases as of December 
31, 19X7, that have initial or remaining lease terms in excess of one year.
Year Ending Minimum Lease
December 31 Payments
19X8............................................................................................................................................. $ 517,000
19X9 ............................................................................................................................................. 506,000
19Y0 ............................................................................................................................................. 459,000
19Y1 ............................................................................................................................................. 375,000
19Y2 ............................................................................................................................................. 343,000
Total minimum lease payments.................................................................................................$2,200,000
Total rental expense in 19X7 and 19X6 for all operating leases was approximately $859,000 and $770,000, 
respectively.
14. Subsequent Event
On February 9, 19X8, the Hospital signed a contract in the amount of $1,050,000 for the purchase of certain 
real estate.
15. Concentrations of Credit Risk
The Hospital is located in Feeling, Illinois. The Hospital grants credit without collateral to its patients, most of 
whom are local residents and are insured under third-party payor agreements. Revenues from patients and 
third-party payors were as follows:
19X7 19X6
Medicare and Medicaid ................................................. .............................................. 20% 19%
Blue Cross ......................................................................... .............................................. 20 19
Other third-party payors
(none over 10%) ......................................................... .............................................. 27 26
Patients ............................................................................. .............................................. 33 36
100% 100%
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The checklists and illustrative financial statements do not include all disclosures 
and presentation items promulated.
SAMPLE NURSING HOME, INC.
.09 Balance Sheets
December 31, 19X2 and 19X1
See accompanying notes to financial statements.
Assets 19X2 19X1 Liabilities and Shareholders' Equity 19X2 19X1
Current assets Current liabilities
Cash and cash equivalents $ 95,000 $ 129,000 Current maturities of long-term debt $ 50,000 $ 50,000
Investments, at cost that Accounts payable 78,000 52,000
approximates market 150,000 — Accrued expenses 175,000 188,000
Assets whose use is limited— Deposits from patients 50,000 45,000
required for current liabilities 50,000 50,000 Income taxes payable 74,000 15,000
Patient accounts receivable less Total current liabilities 427,000 350,000
allowance for doubtful accounts: 
19X2-$6,700; 19X1-$5,300 162,000 152,000
Estimated third-party payor
settlements 71,000 62,000
Interest receivable 7,000 —
Supplies 59,000 57,000 Deferred income tax liability 6,000 14,000
Prepaid expenses 3,000 2,000
Long-term debt, less current
Total current assets 597,000 452,000 maturities 1,700,000 1,750,000
Assets whose use is limited
Under indenture agreement—held
by trustee 176,000 153,000 Shareholders' equity
Common stock, $20 par value;
authorized 5,000 shares; issued
By board for capital improvements 47,000 47,000 and outstanding 3,500 shares 70,000 70,000
Total assets whose use is limited 223,000 200,000 Retained earnings 376,000 229,000
Less assets whose use is limited Total shareholders' equity 446,000 299,000
and that are required for current 
liabilities 50,000 50,000
Noncurrent assets whose use
is limited 173,000 150,000
Property and equipment
Land 205,000 205,000
Land improvements 37,000 32,000
Buildings 1,399,000 1,399,000
Furniture, fixtures, and equipment 228,000 189,000
1,869,000 1,825,000
Less accumulated depreciation 210,000 141,000
Property and equipment, net 1,659,000 1,684,000
Other assets
Note receivable
Bond issuance cost, net of
81,000 72,000
accumulated amortization of 
$38,000 in 19X2 and 
$32,000 in 19X1 42,000 48,000
Land held for investment 27,000 7,000
Total other assets 150,000 127,000 Total liabilities and shareholders'
Total assets $2,579,000 $2,413,000 equity $2,579,000 $2,413,000
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SAMPLE NURSING HOME, INC.
.10 Statements of Income and Retained Earnings
Years Ended December 31, 19X2 and 19X1
Net patient service revenue................................................................................................................
Other revenue........................................................................................................................................
Total revenue ...............................................................................................................................
Expenses
Nursing services................................................................................................................................
Dietary services..................................................................................................................................
General services................................................................................................................................
Administrative services..................................................................................................................
Interest.................................................................................................................................................
Provision for bad debts ..................................................................................................................
Depreciation......................................................................................................................................
Total expenses................................................................................................................................
Income from operations..............................................................................................................
Nonoperating gains-interest and dividends....................................................................................
Income before provision for income taxes.............................................................................
Provision for income taxes..................................................................................................................
Net income....................................................................................................................................
Retained earnings at beginning of year..........................................................................................
Retained earnings at end of year.......................................................................................................
See accompanying notes to financial statements.
19X2 19X1
$2,163,000 $1,949,000
67,000 22,000
2,230,000 1,971,000
1,083,000 1,010,000
228,000 225,000
212,000 212,000
173,000 147,000
164,000 172,000
92,000 83,000
69,000 57,000
2,021,000 1,906,000
209,000 65,000
18,000 7,000
227,000 72,000
80,000 29,000
147,000 43,000
229,000 186,000
$ 376,000 $ 229,000
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SAMPLE NURSING HOME, INC.
.11 Statements of Cash Flows
Years Ended December 31, 19X2 and 19X1
19X2
Cash flows from operating activities and gains
Cash received from residents and third-party payors..............................................................$2,048,000
Cash received from others.............................................................................................................. 67,000
Cash paid to employees and suppliers...........................................................................................(1,679,000)
Interest and dividends received..................................................................................................... 10,000
Interest paid ...................................................................................................................................... (160,000)
Taxes paid.................................................................   (29,000)
Deposits received from patients................................................................................................... 35,000
Deposits refunded to patients....................................................................................................... (30,000)
Net cash provided by operating activities and gains........................................................... 262,000
Cash flows from investing activities
Purchase of land held for investment.......................................................................................... (20,000)
Purchase of other investments ..................................................................................................... (150,000)
Proceeds from sale of property..................................................................................................... —
Additions to property and equipment ........................................................................................ (44,000)
Cash invested in assets whose use is limited............................................................................. (23,000)
Increase in notes receivable............................................................................................................ (9,000)
Net cash used in investing activities........................................................................................ (246,000)
Cash flows from financing activities
Repayment of long-term debt....................................................................................................... (50,000)
Net cash used by financing activities...................................................................................... (50,000)
Net increase (decrease) in cash.......................................................................................................... (34,000)
Cash at beginning of year.................................................................................................................. 129,000
Cash at end of year................................................................................................................................$ 95,000
Reconciliation of Net Income to Net Cash Provided by Operating Activities and Gains
Net income.............................................................................................................................................
Adjustments to reconcile net income to net cash provided by
operating activities and gains
Depreciation..................................................................................................................................
Provision for bad debts ..............................................................................................................
Amortization..................................................................................................................................
Loss on disposal of property.....................................................................................................
Increase (decrease) in deferred income tax liability..............................................................
Net effect of changes in receivables, supplies, prepaid expenses,
accounts payable, accrued expenses, and deposits.........................................................
Net cash provided by operating activities and gains...........................................................
19X1
$1,796,000
22,000
(1,495,000)
10,000
(170,000)
(30,000)
15,000
(20,000)
128,000
2,000
(79,000)
(77,000)
(50,000)
(50,000)
1,000 
128,000 
$ 129,000
43,000
57,000
83,000
6,000
11,000
7,000
(79,000) 
$ 128,000
147,000
69,000
92,000
6,000
(8,000)
(44,000) 
$ 262,000
See accompanying notes to financial statements.
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SAMPLE NURSING HOME, INC.
.12 Notes to Financial Statements
December 31, 19X2 and 19X1
1. Summary of Significant Accounting Policies
Sample Nursing Home, Inc. (Company) operates a 128-bed nursing home in Abacus, New State. A summary 
of the Company's significant accounting policies follows.
Income taxes
The provisions for income taxes are based on net income reported for financial reporting purposes. Deferred 
income taxes arise from temporary differences between financial and income tax reporting of various items 
(principally depreciation). Tax credits are treated as a reduction of the provision for income taxes in the year 
in which the credits arise.
Patient service revenue
Patient service revenue is reported at the estimated net realizable amounts from residents, third-party payors, 
and others for service rendered.
Revenue under third-party payor agreements is subject to audit and retroactive adjustment. Provisions for 
estimated third-party payor settlements are provided in the period the related services are rendered. 
Differences between the estimated amounts accrued and interim and final settlements are reported in 
operations in the year of settlement.
Assets whose use is limited
Assets set aside by the board of directors for capital improvements and assets limited as to use under terms of 
a note indenture are classified as assets whose use is limited.
Property and equipment
Property and equipment are recorded at cost. Depreciation is calculated on the straight-line method over the 
estimated useful lives of depreciable assets.
Bond issuance costs
Costs incurred in issuing bonds are being amortized over the term of the bonds using the straight-line 
method.
Cash and cash equivalents
Cash and cash equivalents include investments in highly liquid debt instruments with a maturity of three 
months or less, excluding amounts whose use is limited by board designation or note indenture.
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2. Assets Whose Use Is Limited
Assets whose use is limited under a note indenture agreement at December 31, 19X2 and 19X1, are 
summarized as follows:
U.S. Treasury obligations, at cost that approximates market........................................
Cash..........................................................................................................................................
Accrued interest income.......................................................................................................
19X2 19X1
$150,000 $130,000
23,000 21,000
3,000 2,000
$176,000 $153,000
Assets set aside by the board of directors for capital improvements consist of certificates of deposit, at a cost 
that approximates market.
3. Long-Term Debt
Long-term debt at December 31, 19X2 and 19X1, was as follows:
9.5 percent notes payable to the City of Abacus, maturing $50,000 
annually through November 1, 19XX, with a final maturity of $1,000,000 
on November 1, 20XX..............................................................................................
19X2 19X1
. $1,750,000 $1,800,000
Less current maturities................................................................................................. 50,000 50,000
$1,700,000 $1,750,000
The notes are collateralized by a first-mortgage lien on all property and equipment of the Company and a 
security interest in all of its receipts. The note indenture requires the maintenance of certain deposits with a 
trustee, which are included in assets whose use is limited.
Future maturities of long-term debt as of December 31, 19X2, follow.
19X3...................................................................................................................................................
19X4...................................................................................................................................................
19X5...................................................................................................................................................
19X6...................................................................................................................................................
19X7...................................................................................................................................................
Thereafter..........................................................................................................................................
$ 50,000
50,000 
50,000 
50,000 
50,000 
1,500,000
Total $1,750,000
4. Income Taxes
The provisions for income taxes on earnings were as follows:
Current
Federal.............................................................................................................................
State..................................................................................................................................
Total current..............................................................................................................
Deferred
Federal.............................................................................................................................
State ..................................................................................................................................
Total deferred............................................................................................................
Total provision for income taxes....................................................................................
19X2 19X1
$72,000
2,000
74,000
$15,000
15,000
6,000 13,000
1,000
6,000 14,000
$80,000 $29,000
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A reconciliation between the "statutory” federal income tax rate and the effective rate in the statements of 
income is as follows:
Statutory tax rate.........................................................................................................................
State taxes, net of federal benefit............................................................................................
Effective tax rate...........................................................................................................................
19X2 19X1
34% 40%
1 1
35% 41%
5. Pension Plan
[The disclosures contained in this note would be similar to the disclosures contained in note 12 of Sample 
Hospital and therefore are not repeated here.]
6. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample 
Hospital and therefore are not repeated here.]
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The checklists and illustrative financial statements do not include all disclosures 
and presentation items promulated.
SAMPLE CONTINUING CARE RETIREMENT COMMUNITY
.13 Balance Sheets
December 31, 19X5 and 19X4
See accompanying notes to financial statements.
Assets 19X5 19X4 Liabilities and Fund Deficit 19X5 19X4
Current assets
Cash..........................................................
Accounts receivable (net of allow­
ance for doubtful accounts of 
$4,000 and $5,000 ...........................
$ 375,000
187,000
$ 330,000
197,000
Current liabilities
Current maturities of long-term debt
Accounts payable..................................
Accrued expenses..................................
Deposits on unoccupied units...........
$ 90,000
180,000 
161,000 
22,000
$ 77,000
174,000 
178,000 
40,000
Supplies...................................................
Prepaid expenses..................................
40,000
15,000
21,000
8,000 Total current liabilities.................... 453,000 469,000
Total current assets........................... 617,000 556,000
Assets whose use is limited
Under note agreement—investments 
By board for capital improvements— 
investments.............................................
2,130,000
100,000
1,753,000
65,000
Long-term debt, less current maturities 8,871,000 8,935,000
2,230,000 1,818,000 Refundable fees........................................ 59,000 144,000
Property and equipment
Land..........................................................
Land improvements.............................
Buildings and improvements..............
Furniture and equipment....................
557,000
205,000
14,573,000
752,000
557,000
203,000
14,564,000
698,000
Estimated obligation to provide future 
services and use of facilities in excess 
of amounts received or to be re­
ceived for such services ....................... 88,000 100,000
Accumulated depreciation..................
16,087,000
1,194,000
16,022,000
742,000 Deferred revenue from advance fees .. 9,304,000 9,585,000
14,893,000 15,280,000
Deferred financing costs (net of accu­
mulated amortization of $28,000 
and $21,000)........................................... 83,000 90,000
Fund deficit................................................. (952,000) (1,489,000)
$17,823,000 $17,744,000 $17,823,000 $17,744,000
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SAMPLE CONTINUING CARE RETIREMENT COMMUNITY
.14 Statements of Revenue and Expenses and Changes in Fund Deficit
Years Ended December 31, 19X5 and 19X4
Revenue
Resident fees earned including amortization of deferred revenue from nonrefundable 
advance fees of $935,000 and $915,000...............................................................................
Patient revenue from nonresidents.............................................................................................
Investment income.........................................................................................................................
Other.................................................................................................................................................
Expenses
Resident care....................................................................................................................................
Dietary...............................................................................................................................................
Health care......................................................................................................................................
Plant.................................................................................................................................................
General and administrative..........................................................................................................
Depreciation....................................................................................................................................
Interest .............................................................................................................................................
Decrease (increase) in obligation to provide future services and use of facilities to
current residents.........................................................................................................................
Income (loss) from operations.............................................................................................
Nonoperating gains—Contributions............................................................................................
Revenue and gains in excess of (less than) expenses.....................................................
Fund deficit, beginning of year.......................................................................................................
Fund deficit, end of year..................................................................................................................
19X5 19X4
$ 3,946,000 $ 3,152,000
249,000 275,000
107,000 78,000
75,000 68,000
4,377,000 3,573,000
649,000 566,000
781,000 701,000
185,000 170,000
491,000 421,000
436,000 445,000
452,000 447,000
967,000 955,000
3,961,000 3,705,000
416,000 (132,000)
12,000 (82,000)
428,000 (214,000)
109,000 73,000
537,000 (141,000)
(1,489,000) (1,348,000)
$ (952,000) $(1,489,000)
See accompanying notes to financial statements.
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SAMPLE CONTINUING CARE RETIREMENT COMMUNITY
.15 Statements of Cash Flows
Years Ended December 31, 19X5 and 19X4
Cash flows from operating activities and nonoperating gains
Cash received from residents and third-party payors...........................................................
Other receipts from operations...................................................................................................
Investment income received.......................................................................................................
Contributions received..................................................................................................................
Cash paid to employees and suppliers......................................................................................
Interest paid....................................................................................................................................
Net cash provided (used) by operating activities and nonoperating gains.............
Cash flows from investing activities
Acquisition of property and equipment..................................................................
Cash invested in assets whose use is limited.........................................................
Assets whose use is limited used for acquisition of property and equipment.
Net cash used by investing activities...............................................................................
Cash flows from financing activities
Proceeds from advance fees and deposits...............................................................................
Refunds of advance fees and deposits......................................................................................
Proceeds from issuance of long-term debt...............................................................................
Repayments of long-term debt
Net cash provided by financing activities.........................................................................
Net increase in cash...........................................................................................................................
Cash at beginning of year................................................................................................................
Cash at end of year ...........................................................................................................................
19X5 19X4
$ 3,252,000 $ 2,341,000
75,000 68,000
109,000 73,000
107,000 78,000
(2,589,000) (2,042,000)
(950,000) 945,000)
4,000 (427,000)
(65,000) (250,000)
(412,000) (238,000)
467,000
477,000 (21,000)
615,000
(46,000)
26,000
(77,000)
857,000
(52,000)
(307,000)
518,000 498,000
45,000 50,000
330,000 280,000
$ 375,000 $ 330,000
Reconciliation of Revenue and Gains in Excess of (Less Than) Expenses to Net Cash 
Provided (Used) by Operating Activities and Nonoperating Gains
Revenue and gains in excess of (less than) expenses................................................................
Adjustments to reconcile revenue and gains in excess of (less than) expenses to net cash
provided (used) by operating activities and nonoperating gains
Amortization of advance fees............................................................................................
Loss (gain) on obligation to provide future services.....................................................
Depreciation and amortization..........................................................................................
Provision for bad debts .......................................................................................................
Net change in other assets and liabilities [details omitted for editorial brevity*] ..
Net cash provided (used) by operating activities and nonoperating
gains....................................................................................................................................
537,000 (141,000)
(935,000) (915,000)
(12,000) 82,000
459,000 475,000
3,000 3,000
(48,000) 69,000
$ 4,000 $ (427,000)
See accompanying notes to financial statements.
8 FASB Statement 95, Statement of Cash Flows, paragraph 29 [AC C25.127], requires that “The reconciliation of net income to net cash flow 
from operating activities ... shall separately report all major classes of reconciling items".
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SAMPLE CONTINUING CARE RETIREMENT COMMUNITY
.16 Notes to Financial Statements
December 31, 19X5 and 19X4
1. Summary of Significant Accounting Policies
Sample Continuing Care Retirement Community (CCRC) provides housing, health care, and other related 
services to residents through the operation of a retirement facility containing 249 apartments and a seventy- 
eight-bed health care facility. A summary of significant accounting policies follows.
Advance fees
Fees paid by a resident upon entering into a continuing care contract, net of the portion thereof that is 
refundable to the resident, are recorded as deferred revenue and are amortized to income using the straight- 
line method over the estimated remaining life expectancy of the resident.
Obligation to provide future services and use of facilities
CCRC annually calculates the present value of the net cost of future services and use of facilities to be 
provided to current residents and compares that amount with the balance of deferred revenue from advance 
fees. If the present value of the net cost of future services and use of facilities exceeds the deferred revenue 
from advance fees, a liability is recorded (obligation to provide future services and use of facilities to current 
residents) with the corresponding charge to income. The obligation is discounted at 9 percent, based on the 
expected long-term rate of return on government obligations.
Investments
Investments, which consist of U.S. Treasury obligations, are stated at cost, which approximates fair market 
value. Interest and investment income are recognized when earned.
2. Property and Equipment
Property and equipment are stated at cost. Donated property is recorded at its estimated fair value at date of 
receipt, which then is treated as cost. Depreciation is computed on the straight-line method based on the 
following estimated useful lives:
Land improvements ............................................................................................................................................... 20 years
Buildings and improvements................................................................................................................................ 40 years
Furniture and equipment........................................................................................................................................5-15 years
When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed 
from the accounts, and any resulting gain or loss is recognized in income for the period. The cost of 
maintenance and repairs is expensed as incurred; significant renewals and betterments are capitalized.
3. Deferred Financing Costs
Deferred financing costs are being amortized using the interest method over the term of the related financing 
agreement.
4. Tax Status
CCRC is a not-for-profit corporation as described in Section 501(c)(3) of the Internal Revenue Code and is 
exempt from federal income taxes pursuant to Section 501(a) of the Internal Revenue Code.
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19X5 19X4
5. Long-Term Debt
Long-term debt at December 31, 19X5 and 19X4, is as follows:
10.75% mortgage note payable........................................
Notes payable to bank—unsecured.................................
Other......................................................................................
...................................$8,901,000
................................. 34,000
................................. 26,000
$8,965,000
14,000
33,000
Less current maturities.......................................................
8,961,000
................................. 90,000
9,012,000
77,000
$8,871,000 $8,935,000
The mortgage note is payable in consecutive monthly installments of principal and interest of $85,425 to May 
20XX. The note is collateralized by a first mortgage on property and equipment with a depreciated value at 
December 31, 19X5, of $14,893,000 and by a pledge of all operating revenue.
As required by the mortgage note agreement, CCRC established an initial debt service reserve fund of 
$1,000,000 at April 15, 19X3. All resident fees received thereafter, net of resident fee refunds and debt service 
payments not to exceed $300,000 annually in the first four years and $200,000 annually thereafter, are to be 
added to the debt service reserve fund until the total sum of $2,050,000 is accumulated. Since June 1, 19X4, 
CCRC is required to deliver to the Trustee $5,500 per month to establish maintenance reserves until the 
aggregate of such payments equals a residential unit reserve and a health care center reserve of $240,000 and 
$90,000, respectively. At December 31, 19X5, the trustee held investments aggregating $2,130,000. Such 
amount had been classified as assets whose use is limited.
Scheduled annual principal maturities of long-term debt for the next five years are as follows:
19X6
19X7
19X8
19X9
19Y0
90,000
90,000
95,000
105,000
105,000
6. Assets Whose Use Is Limited
[The disclosures contained in this note would be similar to the disclosures contained in Note 5 of Sample 
Hospital and therefore are not repeated here.]
7. Pension Plan
[The disclosures contained in this note would be similar to the disclosures contained in Note 12 of Sample 
Hospital and therefore are not repeated here.]
8. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in Note 15 of Sample 
Hospital and therefore are not repeated here.]
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The checklists and illustrative financial statements do not include all disclosures 
and presentation items promulated.
SAMPLE HOME HEALTH AGENCY
.17 Balance Sheets
December 31, 19X5 and 19X4
Assets 19X5 19X4 Liabilities and Fund Balance 19X5 19X4
Current assets Current liabilities
Cash and cash equivalents... $ 74,000 $ 41,000 Current maturities of long­
term debt (note 4).................... $ 13,000 $ 13,000
Investments...............................
Accounts receivable, net of
112,000 102,000
estimated uncollectibles of 
$61,000 in 19X5 and 
$30,000 in 19X4 .................. 752,000 476,000 Accounts payable....................
Accrued payroll and vacation
40,000 21,000
352,000costs........................................
Estimated third-party payor
settlements (note 2).............
496,000
28,000 31,000
Advances from third-party
70,000Other receivables.................... 27,000 22,000 payors........................................ 66,000
Total current assets.................. 965,000 641,000 Total current liabilities........... 647,000 483,000
Assets whose use is limited
(note 3)
Cash............................................ 35,000 35,000
Bank certificates of deposit .. 100,000 100,000
Equipment
135,000 135,000
Long-term debt less current 
maturities (note 4).................... 105,000 118,000
Medical and office equipment 56,000 39,000
Vehicles...................................... 50,000 37,000
106,000 76,000
Less accumulated
depreciation........................... 45,000 24,000
Net equipment .................... 61,000 52,000
Deferred finance charges, net of
accumulated amortization of 
$15,000 in 19X5 and $10,000 
in 19X4........................................ 20,000 25,000 Fund balance................................. 429,000 252,000
$1,181,000 $853,000 $1,181,000 $853,000
See accompanying notes to financial statements.
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SAMPLE HOME HEALTH AGENCY
.18 Statements of Revenue and Expenses and Changes in Fund Balances
Years Ended December 31, 19X5 and 19X4
Net patient service revenue (note 2).................................................................................................
Other revenue........................................................................................................................................
Total revenue.............
Expenses (note 5)
Professional care of patients 
General and administrative .
Occupancy...............................
Provision for bad debts ....
Depreciation..........................
Interest .....................................
Total expenses.......................................................................................................................
Income from operations.......................................................................................................................
Nonoperating gains.............................................................................................................................
Contributions....................................................................................................................................
Investment income...........................................................................................................................
Total nonoperating gains...................................................................................................
Revenue and gains in excess of expenses........................................................................................
Fund balance at beginning of year..............................................................................................
Fund balance at end of year............................................................................................................
19X5 19X4
$4,042,000 $2,687,000
27,000 32,000
4,069,000 2,719,000
2,714,000
1,042,000
90,000
46,000
21,000
16,000
1,835,000
675,000
83,000
21,000
15,000
19,000
3,929,000 2,648,000
140,000 71,000
19,000 15,000
18,000 12,000
37,000 27,000
177,000 98,000
252,000 154,000
$ 429,000 $ 252,000
See accompanying notes to financial statements.
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SAMPLE HOME HEALTH AGENCY
.19 Statements of Cash Flows
Years Ended December 31, 19X5 and 19X4
19X5
Cash flows from operating activities and nonoperating gains
Cash received from customers and third-party payors......................................................... $ 3,721,000
Other receipts from operations................................................................................................... 22,000
Cash paid to employees and suppliers...................................................................................... (3,683,000)
Interest paid.................................................................................................................................... (11,000)
Nonoperating gains....................................................................................................................... 37,000
Net cash provided by operating activities and nonoperating gains...................... 86,000
Cash flows from investing activities
Purchase of equipment................................................................................................................ (30,000)
Purchase of investments.............................................................................................................. (10,000)
Net cash used by investing activities ........................................................................... (40,000)
Cash flows from financing activities
Payment of long-term debt......................................................................................................... (13,000)
Net cash used by financing activities........................................................................... (13,000)
Net increase in cash and cash equivalents.................................................................................... 33,000
Cash and cash equivalents at beginning of year......................................................................... 41,000
Cash and cash equivalents at end of year....................................................................................$ 74,000
by Operating Activities and Nonoperating Gains
Revenue and gains in excess of expenses...................................................................................... 177,000
Adjustments to reconcile revenue and gains in excess of expenses to net cash provided
by operating activities and nonoperating gains
Provision for bad debts................................................................................................................ 46,000
Depreciation and amortization................................................................................................... 26,000
Increase in accounts receivable................................................................................................... (322,000)
Increase in other receivables....................................................................................................... (5,000)
Increase in accounts payable and accrued expenses.............................................................. 163,000
Decrease (increase) in estimated third-party receivables..................................................... (3,000)
Increase in advances from third-party payors......................................................................................4,000
Net cash provided by operating activities and nonoperating gains $ 86,000
19X4
$ 2,542,000 
32,000
(2,540,000)
(14,000)
27,000
47,000
(19,000)
(15,000)
(34,000)
13,000
28,000
$ 41,000
98,000
21,000
20,000
(150,000)
(2,000)
50,000
3,000
7,000
$ 47,000
See accompanying notes to financial statements.
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SAMPLE HOME HEALTH AGENCY
.20 Notes to Financial Statements
Years Ended December 31, 19X5 and 19X4
1. Summary of Significant Accounting Policies
Sample Home Health Agency (the Agency) was incorporated in 19X0 as a not-for-profit corporation. The 
Agency provides health and supportive services to individuals at their homes.
Charity care
The Agency has a policy of providing charity care to patients who are unable to pay. Such patients are 
identified based on financial information obtained from the patient and subsequent analysis. Since the 
Agency does not expect payment, estimated charges for charity care are not included in revenue.
Net patient service revenue
Net patient service revenue represents the estimated net realizable amounts from patients, third-party payors, 
and others for services rendered.
Income taxes
The Agency is a not-for-profit corporation as described in Section 501(c)(3) of the Internal Revenue Code and 
is exempt from federal income taxes on related income pursuant to Section 501(a) of the Code.
Assets whose use is limited
Assets set aside for board-designated purposes are classified as assets whose use is limited.
Investments
Investments consist of U.S. Treasury obligations at cost, which approximates market value.
Equipment
Equipment is recorded at cost. Depreciation is computed using the straight-line method over the estimated 
useful lives of the assets.
Cash and cash equivalents
Cash and cash equivalents include investments in highly liquid debt instruments with a maturity of three 
months or less, excluding amounts whose use is limited by board designation.
2. Third-Party Rate Adjustments and Revenue
Approximately 38 percent in 19X5 and 37 percent in 19X4 of net patient service revenue was derived under 
federal and state third-party reimbursement programs. These revenues are based, in part, on cost reimburse­
ment principles and are subject to audit and retroactive adjustment by the respective third-party fiscal 
intermediaries. In the opinion of management, retroactive adjustments, if any, would not be material to the 
financial position, results of operations or cash flows of the Agency.
3. Board-Designated Assets
The board of directors has designated cash and investments aggregating $135,000 to be used for future major 
capital improvements. Those assets are classified in the balance sheets as assets whose use is limited.
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4. Long-Term Debt
Long-term debt at December 31, 19X5 and 19X4, is as follows:
19X5 19X4
Note payable to bank, interest at 15%, collateralized by equipment with a
depreciated cost in 19X5 of $42,000................................................................$118,000 $131,000
Less current maturities............................................................................................... 13,000 13,000
Long-term debt, less current maturities.................................................................. $105,000 $118,000
Scheduled maturities of long-term debt at December 31,19X5 are as follows:
19X6...................................................................................................................................................
19X7...................................................................................................................................................
19X8...................................................................................................................................................
19X9...................................................................................................................................................
19X0...................................................................................................................................................
Thereafter...........................................................................................................................................
$ 13,000 
13,000 
13,000 
13,000 
13,000 
53,000
Total $118,000
5. Pension Plan
[The disclosures contained in this note would be similar to the disclosures contained in note 12 of Sample 
Hospital.]
6. Charity Care
Charity care represented approximately 3 percent and 4 percent of visits in 19X5 and 19X4, respectively.
7. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample 
Hospital.]
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The checklists and illustrative financial statements do not include all disclosures 
and presentation items promulated.
SAMPLE HEALTH MAINTENANCE ORGANIZATION
.21 Balance Sheets
Assets 19X5
December 31, 19X5 and 19X4
19X419X4 Liabilities and Fund Balance 19X5
Current assets Current liabilities
Unsecured 12% note
Cash..................................... . $ 2,000 $ 193,000 payable to a bank.............
Portion of long-term debt
$ - $ 44,000
Temporary cash payable within one year
investments.................... . 2,935,000 828,000 (note 4)............................... 241,000 109,000
Premiums receivable......... . 358,000 407,000
Accounts payable—medical
Other receivables................ . 263,000 261,000 services............................... 2,245,000 1,471,000
Supplies............................... . 190,000 184,000
Other accounts payable and
Prepaid expenses............... . 197,000 99,000 accrued expenses............. 829,000 661,000
Total current assets .... . 3,945,000 1,972,000 Unearned premium revenue . 141,000 202,000
Total current liabilities........... 3,456,000 2,487,000
Property and equipment 
(notes 3 and 4).................... . 7,559,000 7,062,000
Long-term debt, less portionLess accumulated
depreciation and
1,436,000
payable within one year
amortization.................... . 1,803,000 (note 4)................................... 4,295,000 4,382,000
Commitments and
contingencies (notes 2 and
5,756,000 5,626,000 8)
State guaranty fund deposit 
(note 5)...................................... . 150,000 150,000 Fund balance............................. 2,118,000 900,000
Debt issuance costs, net of
accumulated amortization
of $42,000 in 19X5 and 
$39,000 in 19X4.................. 18,000 21,000
Total liabilities and fund
Total assets........................... . $9,869,000 $7,769,000 balance............................... $9,869,000 $7,769,000
See accompanying notes to financial statements.
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SAMPLE HEALTH MAINTENANCE ORGANIZATION
.22 Statements of Revenue and Expenses and Changes in Fund Balances
Years Ended June 30, 19X5 and 19X4
19X5 19X4
Revenue
Premiums earned....................................................................................................................$27,682,000
Coinsurance........................................................................................................................... 689,000
Interest and other income................................................................................................... 242,000
28,613,000
Expenses
Contracted hospital, physician, and other services ..................................................... 12,749,000
Health centers—medical services...................................................................................... 10,116,000
Health centers—administration........................................................................................ 1,556,000
General administration....................................................................................................... 1,695,000
Membership services............................................................................................................ 527,000
Interest..... .............................................................................................................................. 385,000
Depreciation and amortization.......................................................................................... 367,000
27,395,000
Income from operations ................................................................................................. 1,218,000
Fund balance at beginning of year.................................................................................... 900,000
Fund balance at end of year...............................................................................................$ 2,118,000
$22,500,000
500,000
100,000
23,100,000
9,734,000
8,786,000
1,530,000
1,309,000
440,000
375,000
336,000
22,510,000
590,000
310,000
$ 900,000
See accompanying notes to financial statements.
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SAMPLE HEALTH MAINTENANCE ORGANIZATION
.23 Statements of Cash Flows
Years Ended June 30, 19X5 and 19X4
19X5
Cash flows from operating activities 
Cash received from premiums, stop-loss insurance recoveries, and
coinsurance .................................................................................................................. $ 28,969,000
Cash paid to employees and to providers of health care services........................ (26,405,000)
Interest received................................................................................................................ 230,000
Interest paid....................................................................................................................... (382,000)
Net cash provided by operating activities.............................................................. 2,412,000
Cash flows from investing activities
Additions to property and equipment......................................................................... (497,000)
Net cash used by investing activities...................................................................... (497,000)
Cash flows from financing activities
Proceeds from long-term debt...................................................................................... 300,000
Repayment of long-term debt ...................................................................................... (299,000)
Net cash provided (used) by financing activities................................................. 1,000
Net increase in cash and temporary cash investments .............................................. 1,916,000
Beginning cash and temporary cash investments......................................................... 1,021,000
Ending cash and temporary cash investments..............................................................$ 2,937,000
Reconciliation of Income From Operations to Net Cash Provided
by Operating Activities
Income from operations................................................................................................. 1,218,000
Adjustments to reconcile income from operations to net cash provided by
operating activities
Depreciation and amortization.................................................................................. 370,000
Increase in accounts payable—medical services................................................... 774,000
Increase (decrease) in unearned premium revenue............................................ (61,000)
Decrease in premiums receivable 49,000
Net effect of changes in other receivables, supplies, prepaid expenses, and
other payables................................................................................................................. 62,000
Net cash provided by operating activities......................................................... $ 2,412,000
19X4
$ 24,410,000 
(22,818,000) 
90,000
(372,000)
1,310,000
(121,000)
(121,000)
(1,000,000)
(1,000,000)
189,000
832,000
$ 1,021,000
590,000
339,000
335,000
115,000
84,000
(153,000)
$ 1,310,000
See accompanying notes to financial statements.
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SAMPLE HEALTH MAINTENANCE ORGANIZATION
.24 Notes to Financial Statements
June 30, 19X5 and 19X4
1. Formation and Purpose
Sample Health Maintenance Organization (Sample HMO) was incorporated in 19X0 as a not-for-profit 
corporation for the purpose of providing comprehensive health care services on a prepaid basis and for the 
purpose of establishing and operating organized health maintenance and health care delivery systems.
Sample HMO has been determined to be a qualified health maintenance organization (HMO) under Title XIII 
of the Public Health Service Act.
2. Summary of Significant Accounting Policies 
Temporary cash investments
Temporary cash investments at June 30, 19X5 and 19X4, include a repurchase agreement with a bank and 
certificates of deposit with original maturities of less than ninety days carried at a cost that is equivalent to 
market.
Premiums revenue
Membership contracts are on a yearly basis subject to cancellation by the employer group or Sample HMO 
upon thirty days written notice. Premiums are due monthly and are recognized as revenue during the period 
in which Sample HMO is obligated to provide services to members.
Health care service cost recognition
Sample HMO contracts with various health care providers for the provision of certain medical care services to 
its members. Sample HMO compensates those providers on a capitation basis. As part of a cost control 
incentive program, Sample HMO retains up to XX percent of the capitation as a risk-sharing fund. In the 
event of hospital utilization in excess of budget, those providers bear the risk to the extent of XX percent of the 
capitation fee. Operating expenses include all amounts incurred by Sample HMO under the aforementioned 
contracts.
The cost of other health care services provided or contracted for is accrued in the period in which it is 
provided to a member based in part on estimates, including an accrual for medical services provided but not 
reported to Sample HMO.
Inventories of supplies
Inventories of drugs and other supplies are stated at the lower of cost (first-in, first-out) or market.
Property and equipment
Property and equipment are recorded at cost, less accumulated depreciation. Maintenance and repairs are 
charged to expense, and betterments are capitalized. Property and equipment costing approximately $700,000 
was financed by initial development grants received in 19X1 and 19X2 from the U.S. Department of Health 
and Human Services. This property will be owned by Sample HMO as long as the equipment and facilities 
are used for projects related to the objectives of the Public Health Service Act.
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Depreciation is computed using the straight-line method over the estimated useful lives of the related assets 
as follows:
Building............................................................................................................................................. 40 years
Improvements.................................................................................................................................. 20-25 years
Data processing and laboratory equipment and automobiles.............................................. 3-7 years
Medical equipment......................................................................................................................... 10 years
Office equipment........................................................................................................................... 5-10 years
Amortization of debt issuance costs
Debt issuance costs are deferred and amortized using the interest method over the term of the related debt.
Retirement plan expense
Sample HMO has a retirement plan as more fully described in note 6. Charges to expenses are recognized 
when Sample HMO makes contributions to the plan.
Federal income tax
Sample HMO is exempt from federal income taxes under Section 501(c)(4) of the Internal Revenue Code; 
accordingly, no provision for federal income taxes has been made in the accompanying financial statements.
Reinsurance (stop-loss insurance)
Reinsurance premiums are reported as health care costs, and reinsurance recoveries are reported as revenue.
3. Property and Equipment
19X5 19X4
Property and equipment at June 30, 19X5 and 19X4, consists of the following:
Land.................................................................................... ......................................$ 300,000 $ 300,000
Buildings and improvements........................................ ...................................... 5,473,000 5,459,000
Furniture and equipment.............................................. ...................................... 1,786,000 1,303,000
7,559,000 7,062,000
Less accumulated depreciation................................... ...................................... 1,803,000 1,436,000
$5,756,000 $5,626,000
4. Long-Term Debt
Long-term debt is collateralized by assets with a depreciated cost at June 30, 19X5, of $4,943,000. A summary 
of long-term debt at June 30, 19X5 and 19X4, follows.
19X5 19X4
HHS loan, interest at 7.5%................................................... ...............................$2,020,000 $2,111,000
HHS loan, interest at 9.25%................................................ ............................... 1,658,000 1,694,000
Secured equipment loans..................................................... ............................... 858,000 686,000
4,536,000 4,491,000
Less portion payable within one year............................... ............................... 241,000 109,000
$4,295,000 $4,382,000
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Scheduled principal payments on long-term debt are as follows:
Fiscal Year
19X6
19X7
19X8
19X9
19Y0
Scheduled Principal 
Payments
241,000 
.. 259,000
.. 280,000 
.. 800,000 
.. 2,956,000 
$4,536,000
5. State Guarantee Fund Deposit
In August 19X5 the state in which Sample HMO is domiciled enacted legislation specifically governing 
HMOs. Under this legislation, Sample HMO is required to maintain a deposit of $150,000 with the director of 
the division of insurance of the state.
6. Employee Retirement Plan
Sample HMO has a contributory defined contribution retirement plan covering substantially all employees. 
Expense determined in accordance with the plan formula (4 percent to 10 percent of eligible covered 
compensation) was $354,000 for the year ended June 30, 19X5 ($275,000 for 19X4).
7. Stop-loss Insurance
Sample HMO has entered into a stop-loss insurance agreement with an insurance company to limit its losses 
on individual claims. Under the terms of this agreement, the insurance company will reimburse Sample HMO 
approximately XX percent of the cost of each member's annual hospital services, in excess of a $XXX 
deductible, up to a lifetime limitation of $XXX per member. In the event Sample HMO ceases operations, (a) 
plan benefits will continue for members who are confined in an acute care hospital on the date of insolvency 
until their discharge and (b) plan benefits will continue for any other member until the end of the contract 
period for which premiums have been paid.
Stop-loss insurance premiums of approximately $700,000 and $500,000 are included in health care costs in 
19X5 and 19X4, respectively. Approximately $600,000 and $400,000 of stop-loss insurance recoveries are 
deducted from health care costs in 19X5 and 19X4, respectively.
Included in other receivables is approximately $50,000 recoverable from insurers.
8. Malpractice Claims
Malpractice claims have been asserted against Sample HMO by various claimants. The claims are in various 
stages of processing, and some may ultimately be brought to trial. In the opinion of counsel, the outcome of 
these actions will not have a significant effect on the financial position, results of operations or cash flows of 
Sample HMO. Incidents occurring through June 30, 19X5, may result in the assertion of additional claims. 
Other claims may be asserted arising from past services provided. Management believes that these claims, if 
asserted, would be settled within the limits of insurance coverage.
9. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample 
Hospital.]
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The checklists and illustrative financial statements do not include all disclosures 
and presentation items promulated.
SAMPLE AMBULATORY CARE, INC.
.25 Balance Sheets
December 31, 19X5 and 19X4
Assets 19X5 19X4 Liabilities and Fund Balance 19X5 19X4
Current assets Current liabilities
Cash........................................$
Patient accounts receivable
$ 65,000 $ 76,000 Notes payable (note 3)___ $ 138,000 $ 144,000
less allowance for 
uncollectible accounts
19X5—$15,000; 19X4— 
$5,000 ................................. 290,000 278,000 Accounts payable..................
Accrued payroll, benefits,
52,000 87,000
and taxes............................. 33,000 22,000
Estimated retroactive Estimated retroactive
adjustments—third-party
19,000 32,000
adjustments—third-party
payors (note 4).................. payors (note 4)..................
Financing advance from
30,000 24,000
third-party payor............. — 1,000
Accounts receivable—other 13,000 8,000 Total current liabilities... 253,000 278,000
Supplies.................................
Prepaid expenses and
21,000 18,000
deposits............................... 5,000 9,000
Total current assets......... 413,000 421,000
Property and equipment, at cost
Land......................................
Land improvements.........
Buildings...............................
Equipment...........................
. 100,000 
. 322,000
. 682,000 
. 1,390,000
100,000
322,000
682,000
1,389,000
Less accumulated 
depreciation....................
2,494,000
. 217,000
2,493,000
100,000
Net property and 
equipment ...................... . 2,277,000 2,393,000 Commitment (note 5)........... — —
Advances receivable (note 5) 14,000 5,000 Fund balance.......................... .. 2,451,000 2,541,000
Total assets...................... . $2,704,000 $2,819,000
Total liabilities and fund 
balance............................ ,. $2,704,000 $2,819,000
See accompanying notes to financial statements.
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SAMPLE AMBULATORY CARE, INC.
.26 Statements of Revenue and Expenses and Changes in Fund Balances 
Years Ended December 31, 19X5 and 19X4
Net patient service revenue (note 7) ..............................................................
Operating gains...................................................................................................
Total operating revenue and gains.....................................................
Expenses
Salaries and wages..........................................................................................
Employee benefits..........................................................................................
Supplies ............................................................................................................
Purchased services..........................................................................................
Insurance ..........................................................................................................
Professional fees...............................................................................................
Interest..............................................................................................................
Depreciation.....................................................................................................
Total expenses ........................................................................................
Loss from operations.............................................................................
Nonoperating gain—interest income..............................................................
Expenses in excess of revenue and gains..........................................
Fund balance at beginning of period..............................................................
Fund balance at end of period .........................................................................
19X5
$ 860,000
26,000
886,000
425,000
77,000
107,000
177,000
34,000
27,000
15,000
117,000
979,000
(93,000)
3,000
(90,000)
2,541,000
$2,451,000
19X4
$ 357,000 
14,000
371,000
184,000
54,000
52,000
109,000
22,000
1,000
17,000
100,000
539,000
(168,000)
11,000
(157,000)
2,698,000
$2,541,000
See accompanying notes to financial statements.
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SAMPLE AMBULATORY CARE, INC.
.27 Statements of Cash Flows
Years Ended December 31, 19X5 and 19X4
19X5 19X4
$ 866,000 
21,000 
3,000 
(15,000) 
(870,000)
$ 368,000 
6,000 
11,000 
(16,000) 
(432,000)
5,000 (63,000)
(1,000)
(9,000)
(4,000)
(5,000)
(10,000) (9,000)
(6,000)
144,000
(6,000) 144,000
(11,000)
76,000
72,000
4,000
$ 65,000 $ 76,000
(90,000) (157,000)
117,000
14,000
(12,000)
100,000
4,000
(19,000)
1,000 (2,000)
(25,000) 11,000
$ 5,000 $ (63,000)
Cash flows from operating activities and gains
Cash received from patients and third-party payors...................................................
Cash received from others.................................................................................................
Interest received..................................................................................................................
Interest paid...........................................................................................................................
Cash paid to employees and suppliers...........................................................................
Net cash provided from (used for) operating activities and gains....................
Cash flows from investing activities
Purchase of equipment.......................................................................................................
Advances made....................................................................................................................
Net cash used for investing activities......................................................................
Cash flows from financing activities
Proceeds from notes payable............................................................................................
Payments on notes payable..............................................................................................
Net cash provided from (used for) financing activities.....................................
Net increase (decrease) in cash............................................................................................
Cash at beginning of year.......................................................................................................
Cash at end of year..................................................................................................................
Reconciliation of Expenses in Excess of Revenues and Gains to Net Cash Provided 
From (Used For) Operating Activities and Gains
Net Loss
Adjustments to reconcile expenses in excess of revenues and gains to net cash 
provided from (used for) operating activities and gains
Depreciation .........................................................................................................................
Provision for bad debts.......................................................................................................
Net increase in receivables and net third-party payor adjustments........................
Net decrease (increase) in inventories of supplies, prepaid expenses and
deposits .............................................................................................................................
Net increase (decrease) in accounts payable, accrued expenses and advances
from Blue Cross................................................................................................................
Net cash provided from (used for) operating activities and gains........................
See accompanying notes to financial statements.
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SAMPLE AMBULATORY CARE, INC.
.28 Notes to Financial Statements
December 31, 19X5 and 19X4
1. Summary of Significant Accounting Policies 
Net patient service revenue
Patient service revenue is reported at the estimated net realizable amounts from patients, third-party payors, 
and others for services rendered.
Third-party contractual adjustments
Retroactively calculated third-party contractual adjustments are accrued on an estimated basis in the period 
the related services are rendered. Net patient service revenue is adjusted as required in subsequent periods 
based on final settlements.
Charity care
Sample Ambulatory Care, Inc. has a policy of providing charity care to patients who are unable to pay. Such 
patients are identified and related charges are estimated, based on financial information obtained from the 
patient and subsequent analysis. Since management does not expect payment for charity care, the estimated 
charges are excluded from revenue.
Supplies
Supplies are stated at the lower of cost (first-in, first-out) or net realized value.
Depreciation
Depreciation of property and equipment is computed on the straight-line method over the estimated lives of 
depreciable assets.
Investment income
Investment income and gains on investment transactions are recorded as nonoperating revenue.
2. Formation and Scope of Operations
Sample Ambulatory Care, Inc. was incorporated on September 7, 19X3, to operate an ambulatory care health 
facility to treat or prevent injury and disease, to provide funds or to expend funds to further the treatment or 
prevention of injury or disease, and to develop and participate in activities designed to promote the general 
health of the community.
Three area hospitals—ABC Hospital and Health Center, DEF Hospital, and GHI Hospital—entered into a 
members' agreement to develop this ambulatory care center. In accordance with this agreement, each hospital 
contributed capital of $947,000 to Sample Ambulatory Care, Inc.
Sample Ambulatory Care, Inc. began operations in October 19X3.
3. Related Party Transactions
During 19X3, Sample Ambulatory Care, Inc. entered into a contract with one of the member hospitals 
(managing hospital) for the management of the business and affairs of Sample Ambulatory Care, Inc. Under 
this agreement, Sample Ambulatory Care, Inc. pays $4,000 per month to the managing hospital. The
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agreement with the managing hospital was to remain in effect through December 31, 19X5, but has been 
extended on a month-to-month basis.
In addition, during 19X4, each hospital loaned $48,000 to Sample Ambulatory Care, Inc. in the form of 
promissory notes at an interest rate of prime plus one percent (effective rates of 10 percent and 9 percent in 
19X5 and 19X4, respectively). Of the total $144,000 liability, $48,000 is payable on demand after November 
28, 19X5, to one member hospital, with the remaining portion ($96,000) payable on demand after December 
8, 19X5, to the other two member hospitals. During 19X5, Sample Ambulatory Care, Inc. paid $2,000 to each 
member hospital, thereby reducing the obligation to $138,000
4. Revenue From Contracting Agencies
Sample Ambulatory Care, Inc. participates as provider of health care services to Blue Cross, Medicare, and 
County Indigent Plan patients. Reimbursement for covered services is based on tentative payment rates. Final 
reimbursement rates are determined after submission of annual cost reports and audits thereof by the fiscal 
intermediaries. Provisions for estimated reimbursement adjustments are reported in the financial statements 
in the period that the services are rendered.
5. Advances Receivable
In May 19X4 Sample Ambulatory Care, Inc. entered into a five-year agreement with XYZ Affiliates (XYZ). 
Under this agreement, XYZ is to provide emergency medical services as well as charge and bill each patient 
treated at Sample Ambulatory Care, Inc. Sample Ambulatory Care, Inc. has guaranteed that XYZ will collect 
at least $18,000 per month during the term of this agreement. In any month in which XYZ does not collect the 
minimum guarantee, Sample Ambulatory Care, Inc. advances funds to XYZ to cover the deficiency. Such 
advances are to be repaid to the extent XYZ's net cash collections exceed the minimum guarantee amount. 
Management estimates that the advances will be fully recovered in 19X6.
6. Income Taxes
Sample Ambulatory Care, Inc. is a not-for-profit corporation as described in Section 501(c)(3) of the Internal 
Revenue Code and is exempt from federal income taxes on related income pursuant to Section 501(a) of the 
Code.
7. Charity Care
Sample Ambulatory Care, Inc. has a policy of providing charity care to indigent patients in emergency 
situations. These services, which are excluded from revenues, amounted to $27,000 and $13,000 in 19X3 and 
19X4, respectively, when measured at Sample Ambulatory Care, Inc's established rates.
8. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample 
Hospital.]
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inquiries about specific audit or accounting problems. 
Call Toll Free 
(800) TO-AICPA or 
(800)862-4272
